SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mimedx Group, Inc. – ‘10-Q’ for 3/31/21 – ‘JSON’

On:  Wednesday, 4/28/21, at 4:14pm ET   ·   For:  3/31/21   ·   Accession #:  1376339-21-32   ·   File #:  1-35887

Previous ‘10-Q’:  ‘10-Q’ on 11/4/20 for 9/30/20   ·   Next:  ‘10-Q’ on 8/3/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 4/30/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/28/21  Mimedx Group, Inc.                10-Q        3/31/21   80:6.8M

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    670K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
12: R1          Cover                                               HTML     74K 
13: R2          Condensed Consolidated Balance Sheets               HTML    110K 
14: R3          Condensed Consolidated Balance Sheets               HTML     54K 
                (Parenthetical)                                                  
15: R4          Condensed Consolidated Statements of Operations     HTML     92K 
16: R5          Condensed Consolidated Statements of Stockholders'  HTML     71K 
                Deficit                                                          
17: R6          Condensed Consolidated Statements of Cash Flows     HTML    100K 
18: R7          Nature of Business                                  HTML     30K 
19: R8          Significant Accounting Policies                     HTML     60K 
20: R9          Inventory                                           HTML     29K 
21: R10         Property and Equipment                              HTML     37K 
22: R11         Leases                                              HTML    108K 
23: R12         Intangible Assets                                   HTML     58K 
24: R13         Accrued Expenses                                    HTML     33K 
25: R14         Long Term Debt                                      HTML     76K 
26: R15         Net Loss Per Common Share                           HTML     59K 
27: R16         Equity                                              HTML     36K 
28: R17         Income taxes                                        HTML     26K 
29: R18         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     33K 
                Investing and Financing Activities                               
30: R19         Contractual Commitments and Contingencies           HTML     44K 
31: R20         Revenue Data by Customer Type                       HTML     34K 
32: R21         Share-based Compensation                            HTML     55K 
33: R22         Subsequent Events                                   HTML     23K 
34: R23         Significant Accounting Policies (Policies)          HTML     89K 
35: R24         Significant Accounting Policies Significant         HTML     29K 
                Accounting Policies (Tables)                                     
36: R25         Inventory (Tables)                                  HTML     30K 
37: R26         Property and Equipment (Tables)                     HTML     38K 
38: R27         Leases (Tables)                                     HTML     86K 
39: R28         Intangible Assets (Tables)                          HTML     90K 
40: R29         Accrued Expenses (Tables)                           HTML     32K 
41: R30         Long Term Debt (Tables)                             HTML     61K 
42: R31         Net Loss Per Common Share (Tables)                  HTML     59K 
43: R32         Equity Equity (Tables)                              HTML     29K 
44: R33         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     32K 
                Investing and Financing Activities (Tables)                      
45: R34         Revenue Data by Customer Type (Tables)              HTML     29K 
46: R35         Share-based Compensation (Tables)                   HTML     56K 
47: R36         Nature of Business (Details)                        HTML     33K 
48: R37         Significant Accounting Policies - Narrative         HTML     41K 
                (Details)                                                        
49: R38         Significant Accounting Policies - Assessment of     HTML     36K 
                Revenue under ASC 606 (Details)                                  
50: R39         Inventory (Details)                                 HTML     29K 
51: R40         Property and Equipment - Summary of Property and    HTML     40K 
                Equipment (Details)                                              
52: R41         Property and Equipment - Depreciation Expense       HTML     23K 
                (Details)                                                        
53: R42         Leases - Narrative (Details)                        HTML     24K 
54: R43         Leases - Lease Costs (Details)                      HTML     30K 
55: R44         Leases - Supplemental Balance Sheet Information     HTML     48K 
                (Details)                                                        
56: R45         Leases - Maturity of Lease Liabilities (Details)    HTML     85K 
57: R46         Intangible Assets - Activity Summary (Details)      HTML     52K 
58: R47         Intangible Assets - Amortization Expense (Details)  HTML     23K 
59: R48         Intangible Assets - Estimated Future Amortization   HTML     36K 
                Expense for Intangible Assets (Details)                          
60: R49         Accrued Expenses (Details)                          HTML     38K 
61: R50         Long Term Debt - Term Loan (Details)                HTML    107K 
62: R51         Long Term Debt - Term Loan Debt Issuance Costs      HTML     36K 
                (Details)                                                        
63: R52         Long Term Debt - Term Loan Balances (Details)       HTML     35K 
64: R53         Long Term Debt - Term Loan Interest Expense         HTML     41K 
                (Details)                                                        
65: R54         Long Term Debt - Term Loan Maturity (Details)       HTML     38K 
66: R55         Net Loss Per Common Share - Basic Net Loss Per      HTML     50K 
                Common Share (Details)                                           
67: R56         Net Loss Per Common Share - Diluted Net Loss Per    HTML     57K 
                Common Share (Details)                                           
68: R57         Equity - Narrative (Details)                        HTML     63K 
69: R58         Equity - Changes in Series B Preferred Stock        HTML     33K 
                (Details)                                                        
70: R59         Income taxes (Details)                              HTML     34K 
71: R60         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     37K 
                Investing and Financing Activities (Details)                     
72: R61         Contractual Commitments and Contingencies -         HTML     37K 
                Narrative (Details)                                              
73: R62         Revenue Data by Customer Type (Details)             HTML     32K 
74: R63         Share-based Compensation - Narrative (Details)      HTML     25K 
75: R64         Share-based Compensation - Restricted Stock Awards  HTML     59K 
                (Details)                                                        
76: R65         Share-based Compensation - Stock Incentive Plans    HTML     64K 
                (Details)                                                        
78: XML         IDEA XML File -- Filing Summary                      XML    140K 
11: XML         XBRL Instance -- mdxg-20210331_htm                   XML   1.57M 
77: EXCEL       IDEA Workbook of Financial Reports                  XLSX     95K 
 7: EX-101.CAL  XBRL Calculations -- mdxg-20210331_cal               XML    284K 
 8: EX-101.DEF  XBRL Definitions -- mdxg-20210331_def                XML    391K 
 9: EX-101.LAB  XBRL Labels -- mdxg-20210331_lab                     XML   1.49M 
10: EX-101.PRE  XBRL Presentations -- mdxg-20210331_pre              XML    843K 
 6: EX-101.SCH  XBRL Schema -- mdxg-20210331                         XSD    152K 
79: JSON        XBRL Instance as JSON Data -- MetaLinks              350±   502K 
80: ZIP         XBRL Zipped Folder -- 0001376339-21-000032-xbrl      Zip    251K 


‘JSON’   —   XBRL Instance as JSON Data — MetaLinks


This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.



{
"instance":  {
    "mdxg-20210331.htm":  {
        "axisCustom":  0,
        "axisStandard":  18,
        "contextCount":  125,
        "dts":  {
            "calculationLink":  {
                "local":  [
                    "mdxg-20210331_cal.xml"
                    ]
                },
            "definitionLink":  {
                "local":  [
                    "mdxg-20210331_def.xml"
                    ],
                "remote":  [
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
                    "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
                    ]
                },
            "inline":  {
                "local":  [
                    "mdxg-20210331.htm"
                    ]
                },
            "labelLink":  {
                "local":  [
                    "mdxg-20210331_lab.xml"
                    ],
                "remote":  [
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
                    "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
                    ]
                },
            "presentationLink":  {
                "local":  [
                    "mdxg-20210331_pre.xml"
                    ]
                },
            "referenceLink":  {
                "remote":  [
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
                    "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
                    ]
                },
            "schema":  {
                "local":  [
                    "mdxg-20210331.xsd"
                    ],
                "remote":  [
                    "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
                    "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
                    "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
                    "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
                    "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
                    "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
                    ]
                }
            },
        "elementCount":  501,
        "entityCount":  1,
        "hidden":  {
            "http://xbrl.sec.gov/dei/2020-01-31":  5,
            "total":  5
            },
        "keyCustom":  60,
        "keyStandard":  354,
        "memberCustom":  14,
        "memberStandard":  31,
        "nsprefix":  "mdxg",
        "nsuri":  "http://mimedx.com/20210331",
        "report":  {
            "R1":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "document",
                "isDefault":  "true",
                "longName":  "0001001 - Document - Cover",
                "role":  "http://mimedx.com/role/Cover",
                "shortName":  "Cover",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R10":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2111104 - Disclosure - Property and Equipment",
                "role":  "http://mimedx.com/role/PropertyandEquipment",
                "shortName":  "Property and Equipment",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R11":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:LesseeFinanceLeasesTextBlock",
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2115105 - Disclosure - Leases",
                "role":  "http://mimedx.com/role/Leases",
                "shortName":  "Leases",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:LesseeFinanceLeasesTextBlock",
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R12":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IntangibleAssetsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2121106 - Disclosure - Intangible Assets",
                "role":  "http://mimedx.com/role/IntangibleAssets",
                "shortName":  "Intangible Assets",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IntangibleAssetsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R13":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2126107 - Disclosure - Accrued Expenses",
                "role":  "http://mimedx.com/role/AccruedExpenses",
                "shortName":  "Accrued Expenses",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R14":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2129108 - Disclosure - Long Term Debt",
                "role":  "http://mimedx.com/role/LongTermDebt",
                "shortName":  "Long Term Debt",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R15":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2136109 - Disclosure - Net Loss Per Common Share",
                "role":  "http://mimedx.com/role/NetLossPerCommonShare",
                "shortName":  "Net Loss Per Common Share",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R16":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2140110 - Disclosure - Equity",
                "role":  "http://mimedx.com/role/Equity",
                "shortName":  "Equity",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R17":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2144111 - Disclosure - Income taxes",
                "role":  "http://mimedx.com/role/Incometaxes",
                "shortName":  "Income taxes",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R18":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2146112 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities",
                "role":  "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities",
                "shortName":  "Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R19":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2149113 - Disclosure - Contractual Commitments and Contingencies",
                "role":  "http://mimedx.com/role/ContractualCommitmentsandContingencies",
                "shortName":  "Contractual Commitments and Contingencies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R2":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
                "role":  "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
                "shortName":  "CONDENSED CONSOLIDATED BALANCE SHEETS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R20":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2151114 - Disclosure - Revenue Data by Customer Type",
                "role":  "http://mimedx.com/role/RevenueDatabyCustomerType",
                "shortName":  "Revenue Data by Customer Type",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R21":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2154115 - Disclosure - Share-based Compensation",
                "role":  "http://mimedx.com/role/SharebasedCompensation",
                "shortName":  "Share-based Compensation",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R22":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2159116 - Disclosure - Subsequent Events",
                "role":  "http://mimedx.com/role/SubsequentEvents",
                "shortName":  "Subsequent Events",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R23":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2204201 - Disclosure - Significant Accounting Policies (Policies)",
                "role":  "http://mimedx.com/role/SignificantAccountingPoliciesPolicies",
                "shortName":  "Significant Accounting Policies (Policies)",
                "subGroupType":  "policies",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R24":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2305301 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Tables)",
                "role":  "http://mimedx.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables",
                "shortName":  "Significant Accounting Policies Significant Accounting Policies (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R25":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2309302 - Disclosure - Inventory (Tables)",
                "role":  "http://mimedx.com/role/InventoryTables",
                "shortName":  "Inventory (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R26":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2312303 - Disclosure - Property and Equipment (Tables)",
                "role":  "http://mimedx.com/role/PropertyandEquipmentTables",
                "shortName":  "Property and Equipment (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R27":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LeaseCostTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2316304 - Disclosure - Leases (Tables)",
                "role":  "http://mimedx.com/role/LeasesTables",
                "shortName":  "Leases (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LeaseCostTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R28":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2322305 - Disclosure - Intangible Assets (Tables)",
                "role":  "http://mimedx.com/role/IntangibleAssetsTables",
                "shortName":  "Intangible Assets (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R29":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2327306 - Disclosure - Accrued Expenses (Tables)",
                "role":  "http://mimedx.com/role/AccruedExpensesTables",
                "shortName":  "Accrued Expenses (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R3":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:TemporaryEquityParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unitRef":  "usdPerShare",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
                "role":  "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
                "shortName":  "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:TemporaryEquitySharesOutstanding",
                        "us-gaap:TemporaryEquitySharesOutstanding",
                        "us-gaap:TemporaryEquitySharesIssued",
                        "us-gaap:TemporaryEquitySharesIssued",
                        "us-gaap:TemporaryEquitySharesAuthorized",
                        "span",
                        "div",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "INF",
                    "lang":  "en-US",
                    "name":  "us-gaap:TemporaryEquitySharesAuthorized",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R30":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "mdxg:ScheduleofDebtIssuanceCostsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2330307 - Disclosure - Long Term Debt (Tables)",
                "role":  "http://mimedx.com/role/LongTermDebtTables",
                "shortName":  "Long Term Debt (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "mdxg:ScheduleofDebtIssuanceCostsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R31":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2337308 - Disclosure - Net Loss Per Common Share (Tables)",
                "role":  "http://mimedx.com/role/NetLossPerCommonShareTables",
                "shortName":  "Net Loss Per Common Share (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R32":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:TemporaryEquityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2341309 - Disclosure - Equity Equity (Tables)",
                "role":  "http://mimedx.com/role/EquityEquityTables",
                "shortName":  "Equity Equity (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:TemporaryEquityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R33":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2347310 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)",
                "role":  "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables",
                "shortName":  "Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R34":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2352311 - Disclosure - Revenue Data by Customer Type (Tables)",
                "role":  "http://mimedx.com/role/RevenueDatabyCustomerTypeTables",
                "shortName":  "Revenue Data by Customer Type (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R35":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2355312 - Disclosure - Share-based Compensation (Tables)",
                "role":  "http://mimedx.com/role/SharebasedCompensationTables",
                "shortName":  "Share-based Compensation (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R36":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxExpenseBenefit",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2402401 - Disclosure - Nature of Business (Details)",
                "role":  "http://mimedx.com/role/NatureofBusinessDetails",
                "shortName":  "Nature of Business (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i8c5d58a7889a43b99b3c58d9b2e357ac_D20210101-20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "us-gaap:ProceedsFromIncomeTaxRefunds",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R37":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2406402 - Disclosure - Significant Accounting Policies - Narrative (Details)",
                "role":  "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails",
                "shortName":  "Significant Accounting Policies - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R38":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2407403 - Disclosure - Significant Accounting Policies - Assessment of Revenue under ASC 606 (Details)",
                "role":  "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details",
                "shortName":  "Significant Accounting Policies - Assessment of Revenue under ASC 606 (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "ic223d806cec34e7d8a314688c4dd5250_D20210101-20210331",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R39":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InventoryRawMaterials",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2410404 - Disclosure - Inventory (Details)",
                "role":  "http://mimedx.com/role/InventoryDetails",
                "shortName":  "Inventory (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InventoryRawMaterials",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R4":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
                "role":  "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
                "shortName":  "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:SellingGeneralAndAdministrativeExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R40":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:PropertyPlantAndEquipmentTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2413405 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)",
                "role":  "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails",
                "shortName":  "Property and Equipment - Summary of Property and Equipment (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:PropertyPlantAndEquipmentTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R41":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:Depreciation",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2414406 - Disclosure - Property and Equipment - Depreciation Expense (Details)",
                "role":  "http://mimedx.com/role/PropertyandEquipmentDepreciationExpenseDetails",
                "shortName":  "Property and Equipment - Depreciation Expense (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R42":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "mdxg:NumberOfSubleasedWarehouseSpaces",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "warehousespace",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2417407 - Disclosure - Leases - Narrative (Details)",
                "role":  "http://mimedx.com/role/LeasesNarrativeDetails",
                "shortName":  "Leases - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "mdxg:NumberOfSubleasedWarehouseSpaces",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "warehousespace",
                    "xsiNil":  "false"
                    }
                },
            "R43":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:LeaseCostTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OperatingLeaseCost",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2418408 - Disclosure - Leases - Lease Costs (Details)",
                "role":  "http://mimedx.com/role/LeasesLeaseCostsDetails",
                "shortName":  "Leases - Lease Costs (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:LeaseCostTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OperatingLeaseCost",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R44":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "mdxg:AssetsAndLiabilitiesLesseeTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OperatingLeaseRightOfUseAsset",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2419409 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
                "role":  "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails",
                "shortName":  "Leases - Supplemental Balance Sheet Information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "mdxg:AssetsAndLiabilitiesLesseeTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OperatingLeaseRightOfUseAsset",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R45":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
                        "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2420410 - Disclosure - Leases - Maturity of Lease Liabilities (Details)",
                "role":  "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails",
                "shortName":  "Leases - Maturity of Lease Liabilities (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
                        "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R46":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                        "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2423411 - Disclosure - Intangible Assets - Activity Summary (Details)",
                "role":  "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails",
                "shortName":  "Intangible Assets - Activity Summary (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                        "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R47":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AmortizationOfIntangibleAssets",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2424412 - Disclosure - Intangible Assets - Amortization Expense (Details)",
                "role":  "http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails",
                "shortName":  "Intangible Assets - Amortization Expense (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R48":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2425413 - Disclosure - Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)",
                "role":  "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails",
                "shortName":  "Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R49":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2428414 - Disclosure - Accrued Expenses (Details)",
                "role":  "http://mimedx.com/role/AccruedExpensesDetails",
                "shortName":  "Accrued Expenses (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R5":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i93ca0831222e45a5809297d66d5cdf38_I20191231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SharesOutstanding",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT",
                "role":  "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
                "shortName":  "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i93ca0831222e45a5809297d66d5cdf38_I20191231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SharesOutstanding",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R50":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i12a90fd68624421490510c26df231be4_I20200702",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtInstrumentFaceAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2431415 - Disclosure - Long Term Debt - Term Loan (Details)",
                "role":  "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                "shortName":  "Long Term Debt - Term Loan (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i12a90fd68624421490510c26df231be4_I20200702",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtInstrumentFaceAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R51":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "id251b9a55a4e4cbaa4fb1e32c616ed14_I20200702",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtInstrumentUnamortizedDiscount",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2432416 - Disclosure - Long Term Debt - Term Loan Debt Issuance Costs (Details)",
                "role":  "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                "shortName":  "Long Term Debt - Term Loan Debt Issuance Costs (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i2043c1b2500640d981b81c16eccfc76d_I20200702",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtInstrumentUnamortizedDiscount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R52":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LongTermDebt",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2433417 - Disclosure - Long Term Debt - Term Loan Balances (Details)",
                "role":  "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
                "shortName":  "Long Term Debt - Term Loan Balances (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfDebtTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i712a8b2f7513421187a577e1b91190f1_I20210331",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtInstrumentCarryingAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R53":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "mdxg:ScheduleofInterestExpenseTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i3bc2aa5c35a34e8ca290961011b95769_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InterestExpenseDebtExcludingAmortization",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2434418 - Disclosure - Long Term Debt - Term Loan Interest Expense (Details)",
                "role":  "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails",
                "shortName":  "Long Term Debt - Term Loan Interest Expense (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "mdxg:ScheduleofInterestExpenseTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i3bc2aa5c35a34e8ca290961011b95769_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InterestExpenseDebtExcludingAmortization",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R54":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2435419 - Disclosure - Long Term Debt - Term Loan Maturity (Details)",
                "role":  "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails",
                "shortName":  "Long Term Debt - Term Loan Maturity (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R55":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2438420 - Disclosure - Net Loss Per Common Share - Basic Net Loss Per Common Share (Details)",
                "role":  "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
                "shortName":  "Net Loss Per Common Share - Basic Net Loss Per Common Share (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R56":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2439421 - Disclosure - Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details)",
                "role":  "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails",
                "shortName":  "Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "0",
                    "lang":  "en-US",
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R57":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:TemporaryEquityParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unitRef":  "usdPerShare",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2442422 - Disclosure - Equity - Narrative (Details)",
                "role":  "http://mimedx.com/role/EquityNarrativeDetails",
                "shortName":  "Equity - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i4a22bd0dfca6403ab30893dddaa7c76b_D20200702-20200702",
                    "decimals":  "INF",
                    "lang":  "en-US",
                    "name":  "us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R58":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:TemporaryEquitySharesIssued",
                        "us-gaap:TemporaryEquitySharesIssued",
                        "us-gaap:TemporaryEquitySharesAuthorized",
                        "span",
                        "div",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idc24c8b558d34cbd9fe45199dec22d3f_I20201231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:TemporaryEquitySharesOutstanding",
                    "reportCount":  1,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2443423 - Disclosure - Equity - Changes in Series B Preferred Stock (Details)",
                "role":  "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
                "shortName":  "Equity - Changes in Series B Preferred Stock (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:TemporaryEquityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i79a0a8364b6547af863f43b94ba61547_I20201231",
                    "decimals":  "INF",
                    "lang":  "en-US",
                    "name":  "us-gaap:TemporaryEquitySharesOutstanding",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R59":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2445424 - Disclosure - Income taxes (Details)",
                "role":  "http://mimedx.com/role/IncometaxesDetails",
                "shortName":  "Income taxes (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    }
                },
            "R6":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
                "role":  "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
                "shortName":  "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R60":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InterestPaid",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2448425 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details)",
                "role":  "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails",
                "shortName":  "Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InterestPaid",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R61":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeaseTermOfContract",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2450426 - Disclosure - Contractual Commitments and Contingencies - Narrative (Details)",
                "role":  "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails",
                "shortName":  "Contractual Commitments and Contingencies - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeaseTermOfContract",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R62":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "mdxg:NumberofDistributionChannels",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "distributionchannel",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2453427 - Disclosure - Revenue Data by Customer Type (Details)",
                "role":  "http://mimedx.com/role/RevenueDatabyCustomerTypeDetails",
                "shortName":  "Revenue Data by Customer Type (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "mdxg:NumberofDistributionChannels",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "distributionchannel",
                    "xsiNil":  "false"
                    }
                },
            "R63":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2456428 - Disclosure - Share-based Compensation - Narrative (Details)",
                "role":  "http://mimedx.com/role/SharebasedCompensationNarrativeDetails",
                "shortName":  "Share-based Compensation - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idfb84d716cfa4b50bbafd16403b2f9bc_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R64":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i5eeafc9371154e9aa67f93d8abbc0676_I20201231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2457429 - Disclosure - Share-based Compensation - Restricted Stock Awards (Details)",
                "role":  "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails",
                "shortName":  "Share-based Compensation - Restricted Stock Awards (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i5eeafc9371154e9aa67f93d8abbc0676_I20201231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R65":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idc24c8b558d34cbd9fe45199dec22d3f_I20201231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2458430 - Disclosure - Share-based Compensation - Stock Incentive Plans (Details)",
                "role":  "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails",
                "shortName":  "Share-based Compensation - Stock Incentive Plans (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "idc24c8b558d34cbd9fe45199dec22d3f_I20201231",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R7":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2101101 - Disclosure - Nature of Business",
                "role":  "http://mimedx.com/role/NatureofBusiness",
                "shortName":  "Nature of Business",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R8":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2103102 - Disclosure - Significant Accounting Policies",
                "role":  "http://mimedx.com/role/SignificantAccountingPolicies",
                "shortName":  "Significant Accounting Policies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InventoryDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2108103 - Disclosure - Inventory",
                "role":  "http://mimedx.com/role/Inventory",
                "shortName":  "Inventory",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "mdxg-20210331.htm",
                    "contextRef":  "i38e3ad0533a748edb9b3b38285e6f835_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InventoryDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                }
            },
        "segmentCount":  49,
        "tag":  {
            "dei_AmendmentFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
                            "label":  "Amendment Flag",
                            "terseLabel":  "Amendment Flag"
                            }
                        }
                    },
                "localname":  "AmendmentFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_CityAreaCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Area code of city",
                            "label":  "City Area Code",
                            "terseLabel":  "City Area Code"
                            }
                        }
                    },
                "localname":  "CityAreaCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CoverAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cover page.",
                            "label":  "Cover [Abstract]",
                            "terseLabel":  "Cover [Abstract]"
                            }
                        }
                    },
                "localname":  "CoverAbstract",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "dei_CurrentFiscalYearEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "End date of current fiscal year in the format --MM-DD.",
                            "label":  "Current Fiscal Year End Date",
                            "terseLabel":  "Current Fiscal Year End Date"
                            }
                        }
                    },
                "localname":  "CurrentFiscalYearEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "gMonthDayItemType"
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
                            "label":  "Document Fiscal Period Focus",
                            "terseLabel":  "Document Fiscal Period Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalPeriodFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "fiscalPeriodItemType"
                },
            "dei_DocumentFiscalYearFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This is focus fiscal year of the document report in YYYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006.",
                            "label":  "Document Fiscal Year Focus",
                            "terseLabel":  "Document Fiscal Year Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalYearFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "gYearItemType"
                },
            "dei_DocumentPeriodEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The end date of the period reflected on the cover page if a periodic report.  For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date.  The format of the date is YYYY-MM-DD.",
                            "label":  "Document Period End Date",
                            "terseLabel":  "Document Period End Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentQuarterlyReport":  {
                "auth_ref":  [
                    "r425"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an quarterly report.",
                            "label":  "Document Quarterly Report",
                            "terseLabel":  "Document Quarterly Report"
                            }
                        }
                    },
                "localname":  "DocumentQuarterlyReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentTransitionReport":  {
                "auth_ref":  [
                    "r426"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a transition report.",
                            "label":  "Document Transition Report",
                            "terseLabel":  "Document Transition Report"
                            }
                        }
                    },
                "localname":  "DocumentTransitionReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentType":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
                            "label":  "Document Type",
                            "terseLabel":  "Document Type"
                            }
                        }
                    },
                "localname":  "DocumentType",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "submissionTypeItemType"
                },
            "dei_EntityAddressAddressLine1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name",
                            "label":  "Entity Address, Address Line One",
                            "terseLabel":  "Entity Address, Address Line One"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine1",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCityOrTown":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the City or Town",
                            "label":  "Entity Address, City or Town",
                            "terseLabel":  "Entity Address, City or Town"
                            }
                        }
                    },
                "localname":  "EntityAddressCityOrTown",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressPostalZipCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Code for the postal or zip code",
                            "label":  "Entity Address, Postal Zip Code",
                            "terseLabel":  "Entity Address, Postal Zip Code"
                            }
                        }
                    },
                "localname":  "EntityAddressPostalZipCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressStateOrProvince":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the state or province.",
                            "label":  "Entity Address, State or Province",
                            "terseLabel":  "Entity Address, State or Province"
                            }
                        }
                    },
                "localname":  "EntityAddressStateOrProvince",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "stateOrProvinceItemType"
                },
            "dei_EntityCentralIndexKey":  {
                "auth_ref":  [
                    "r427"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK.",
                            "label":  "Entity Central Index Key",
                            "terseLabel":  "Entity Central Index Key"
                            }
                        }
                    },
                "localname":  "EntityCentralIndexKey",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "centralIndexKeyItemType"
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
                            "label":  "Entity Common Stock, Shares Outstanding",
                            "terseLabel":  "Entity Common Stock, Shares Outstanding"
                            }
                        }
                    },
                "localname":  "EntityCommonStockSharesOutstanding",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "dei_EntityCurrentReportingStatus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Current Reporting Status",
                            "terseLabel":  "Entity Current Reporting Status"
                            }
                        }
                    },
                "localname":  "EntityCurrentReportingStatus",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityEmergingGrowthCompany":  {
                "auth_ref":  [
                    "r427"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria.",
                            "label":  "Entity Emerging Growth Company",
                            "terseLabel":  "Entity Emerging Growth Company"
                            }
                        }
                    },
                "localname":  "EntityEmergingGrowthCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityFileNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
                            "label":  "Entity File Number",
                            "terseLabel":  "Entity File Number"
                            }
                        }
                    },
                "localname":  "EntityFileNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "fileNumberItemType"
                },
            "dei_EntityFilerCategory":  {
                "auth_ref":  [
                    "r427"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Filer Category",
                            "terseLabel":  "Entity Filer Category"
                            }
                        }
                    },
                "localname":  "EntityFilerCategory",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "filerCategoryItemType"
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation.",
                            "label":  "Entity Incorporation, State or Country Code",
                            "terseLabel":  "Entity Incorporation, State or Country Code"
                            }
                        }
                    },
                "localname":  "EntityIncorporationStateCountryCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "edgarStateCountryItemType"
                },
            "dei_EntityInteractiveDataCurrent":  {
                "auth_ref":  [
                    "r428"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
                            "label":  "Entity Interactive Data Current",
                            "terseLabel":  "Entity Interactive Data Current"
                            }
                        }
                    },
                "localname":  "EntityInteractiveDataCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityRegistrantName":  {
                "auth_ref":  [
                    "r427"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
                            "label":  "Entity Registrant Name",
                            "terseLabel":  "Entity Registrant Name"
                            }
                        }
                    },
                "localname":  "EntityRegistrantName",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityShellCompany":  {
                "auth_ref":  [
                    "r427"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
                            "label":  "Entity Shell Company",
                            "terseLabel":  "Entity Shell Company"
                            }
                        }
                    },
                "localname":  "EntityShellCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntitySmallBusiness":  {
                "auth_ref":  [
                    "r427"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC).",
                            "label":  "Entity Small Business",
                            "terseLabel":  "Entity Small Business"
                            }
                        }
                    },
                "localname":  "EntitySmallBusiness",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityTaxIdentificationNumber":  {
                "auth_ref":  [
                    "r427"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
                            "label":  "Entity Tax Identification Number",
                            "terseLabel":  "Entity Tax Identification Number"
                            }
                        }
                    },
                "localname":  "EntityTaxIdentificationNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "employerIdItemType"
                },
            "dei_LocalPhoneNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Local phone number for entity.",
                            "label":  "Local Phone Number",
                            "terseLabel":  "Local Phone Number"
                            }
                        }
                    },
                "localname":  "LocalPhoneNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_Security12bTitle":  {
                "auth_ref":  [
                    "r423"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Title of a 12(b) registered security.",
                            "label":  "Title of 12(b) Security",
                            "terseLabel":  "Title of 12(b) Security"
                            }
                        }
                    },
                "localname":  "Security12bTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_SecurityExchangeName":  {
                "auth_ref":  [
                    "r424"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the Exchange on which a security is registered.",
                            "label":  "Security Exchange Name",
                            "terseLabel":  "Security Exchange Name"
                            }
                        }
                    },
                "localname":  "SecurityExchangeName",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "edgarExchangeCodeItemType"
                },
            "dei_TradingSymbol":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Trading symbol of an instrument as listed on an exchange.",
                            "label":  "Trading Symbol",
                            "terseLabel":  "Trading Symbol"
                            }
                        }
                    },
                "localname":  "TradingSymbol",
                "nsuri":  "http://xbrl.sec.gov/dei/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Cover"
                    ],
                "xbrltype":  "tradingSymbolItemType"
                },
            "mdxg_AccruedClinicalTrialsCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/AccruedExpensesDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued Clinical Trials, Current",
                            "label":  "Accrued Clinical Trials, Current",
                            "terseLabel":  "Accrued clinical trials"
                            }
                        }
                    },
                "localname":  "AccruedClinicalTrialsCurrent",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/AccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_AccruedRebates":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/AccruedExpensesDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued Rebates",
                            "label":  "Accrued Rebates",
                            "terseLabel":  "Accrued rebates"
                            }
                        }
                    },
                "localname":  "AccruedRebates",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/AccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_AccruedSettlementCostsCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/AccruedExpensesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued Settlement Costs, Current",
                            "label":  "Accrued Settlement Costs, Current",
                            "terseLabel":  "Settlement costs"
                            }
                        }
                    },
                "localname":  "AccruedSettlementCostsCurrent",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/AccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders",
                            "label":  "Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders",
                            "terseLabel":  "Dividends on Series B Convertible Preferred Stock",
                            "totalLabel":  "Total adjustments"
                            }
                        }
                    },
                "localname":  "AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_AmendedTermLoanAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amended Term Loan Agreement [Member]",
                            "label":  "Amended Term Loan Agreement [Member]",
                            "terseLabel":  "Amended Term Loan Agreement"
                            }
                        }
                    },
                "localname":  "AmendedTermLoanAgreementMember",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_AssetRetirementCostMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Asset Retirement Cost [Member]",
                            "label":  "Asset Retirement Cost [Member]",
                            "terseLabel":  "Asset retirement cost"
                            }
                        }
                    },
                "localname":  "AssetRetirementCostMember",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_AssetsAndLiabilitiesLesseeTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Assets And Liabilities, Lessee",
                            "label":  "Assets And Liabilities, Lessee [Table Text Block]",
                            "terseLabel":  "Assets and Liabilities"
                            }
                        }
                    },
                "localname":  "AssetsAndLiabilitiesLesseeTableTextBlock",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "mdxg_CARESActMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "CARES Act",
                            "label":  "CARES Act [Member]",
                            "terseLabel":  "CARES Act"
                            }
                        }
                    },
                "localname":  "CARESActMember",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/IncometaxesDetails",
                    "http://mimedx.com/role/NatureofBusinessDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "-- None.  No documentation exists for this element. --",
                            "label":  "Computation of basic and diluted net loss per share [Abstract]",
                            "terseLabel":  "Computation of basic and diluted net loss per share [Abstract]"
                            }
                        }
                    },
                "localname":  "ComputationOfBasicAndDilutedNetLossPerShareAbstract",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "mdxg_ContingencyLossNumberOfFormerClinicians":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contingency Loss, Number Of Former Clinicians",
                            "label":  "Contingency Loss, Number Of Former Clinicians",
                            "terseLabel":  "Number of gormer clinicans"
                            }
                        }
                    },
                "localname":  "ContingencyLossNumberOfFormerClinicians",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "mdxg_ContingencyLossNumberOfFormerHealthcareProviders":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contingency Loss, Number Of Former Healthcare Providers",
                            "label":  "Contingency Loss, Number Of Former Healthcare Providers",
                            "terseLabel":  "Number of healthcare providers"
                            }
                        }
                    },
                "localname":  "ContingencyLossNumberOfFormerHealthcareProviders",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "mdxg_ContingencyLossNumberOfSecuritiesClassActions":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contingency Loss, Number Of Securities Class Actions",
                            "label":  "Contingency Loss, Number Of Securities Class Actions",
                            "terseLabel":  "Number of securities class actions"
                            }
                        }
                    },
                "localname":  "ContingencyLossNumberOfSecuritiesClassActions",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "mdxg_ContingencyLossNumberofFormerEmployees":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contingency Loss, Number Of Former Employees",
                            "label":  "Contingency Loss, Number of Former Employees",
                            "terseLabel":  "Number of former employees"
                            }
                        }
                    },
                "localname":  "ContingencyLossNumberofFormerEmployees",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "mdxg_CreditFacilitiesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Credit Facilities [Member]",
                            "label":  "Credit Facilities [Member]",
                            "terseLabel":  "Credit Facilities"
                            }
                        }
                    },
                "localname":  "CreditFacilitiesMember",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_CustomerAndSupplierRelationshipsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Customer And Supplier Relationships",
                            "label":  "Customer And Supplier Relationships [Member]",
                            "terseLabel":  "Customer and supplier relationships"
                            }
                        }
                    },
                "localname":  "CustomerAndSupplierRelationshipsMember",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_DebtCovenantMinimumLiquidity":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Debt Covenant, Minimum Liquidity",
                            "label":  "Debt Covenant, Minimum Liquidity",
                            "terseLabel":  "Debt covenant, minimum liquidity"
                            }
                        }
                    },
                "localname":  "DebtCovenantMinimumLiquidity",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_DebtInstrumentCommitmentFees":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_InterestExpenseDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Debt Instrument, Commitment Fees",
                            "label":  "Debt Instrument, Commitment Fees",
                            "terseLabel":  "Commitment fee"
                            }
                        }
                    },
                "localname":  "DebtInstrumentCommitmentFees",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_DebtInstrumentDefaultInterestRate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Debt Instrument, Default Interest Rate",
                            "label":  "Debt Instrument, Default Interest Rate",
                            "terseLabel":  "Default interest rate (percent)"
                            }
                        }
                    },
                "localname":  "DebtInstrumentDefaultInterestRate",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "mdxg_DebtInstrumentInterestRateFloorPercentage":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Debt Instrument, Interest Rate, Floor Percentage",
                            "label":  "Debt Instrument, Interest Rate, Floor Percentage",
                            "terseLabel":  "Debt instrument, interest rate, floor (percent)"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateFloorPercentage",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Percent",
                            "label":  "Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Percent",
                            "terseLabel":  "Debt instrument, prepayment make-whole premium as percent of prepaid principal (percent)"
                            }
                        }
                    },
                "localname":  "DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Plus Accrued Interest, Percent",
                            "label":  "Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Plus Accrued Interest, Percent",
                            "terseLabel":  "Debt instrument, prepayment make-whole premium as percent of prepaid principal, plus accrued interest (percent)"
                            }
                        }
                    },
                "localname":  "DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Debt Instrument, Unused Capacity, Commitment Fee Percentage",
                            "label":  "Debt Instrument, Unused Capacity, Commitment Fee Percentage",
                            "terseLabel":  "Additional commitment fee (percent)"
                            }
                        }
                    },
                "localname":  "DebtInstrumentUnusedCapacityCommitmentFeePercentage",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "mdxg_DeemedDividendsOnTemporaryEquity":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Deemed Dividends On Temporary Equity",
                            "label":  "Deemed Dividends On Temporary Equity",
                            "terseLabel":  "Deemed dividends on Series B Convertible Preferred Stock"
                            }
                        }
                    },
                "localname":  "DeemedDividendsOnTemporaryEquity",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021 [Member]",
                            "label":  "Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021 [Member]",
                            "terseLabel":  "Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021"
                            }
                        }
                    },
                "localname":  "DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Effective Income Tax Rate Reconciliation, Discrete Items",
                            "label":  "Effective Income Tax Rate Reconciliation, Discrete Items",
                            "terseLabel":  "Effective income tax rate impact of discrete items"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationDiscreteItems",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/IncometaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Effective Income Tax Rate Reconciliation, Net Operating Loss Carryforward",
                            "label":  "Effective Income Tax Rate Reconciliation, Net Operating Loss Carryforward",
                            "terseLabel":  "Tax benefit recognized with respect to net operating loss"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/IncometaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value Of Non-Cash Consideration Received For Option Exercise",
                            "label":  "Fair value Of Non-Cash Consideration Received For Option Exercise",
                            "terseLabel":  "Fair value of non-cash consideration received for option exercise"
                            }
                        }
                    },
                "localname":  "FairValueOfNonCashConsiderationReceivedForOptionExercise",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_FinancingTransactionsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Financing Transactions [Member]",
                            "label":  "Financing Transactions [Member]",
                            "terseLabel":  "Financing Transactions"
                            }
                        }
                    },
                "localname":  "FinancingTransactionsMember",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
                            "terseLabel":  "Thereafter"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_GroupPurchasingOrganizationAdministrativeFeesasPercentofPurchaseVolume":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Group Purchasing Organization Administrative Fees as Percent of Purchase Volume",
                            "label":  "Group Purchasing Organization Administrative Fees as Percent of Purchase Volume",
                            "terseLabel":  "Group purchasing organization administrative fees (as a percent)"
                            }
                        }
                    },
                "localname":  "GroupPurchasingOrganizationAdministrativeFeesasPercentofPurchaseVolume",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Hayfin Loan Agreement Delayed Draw Term Loan [Member]",
                            "label":  "Hayfin Loan Agreement Delayed Draw Term Loan [Member]",
                            "terseLabel":  "Hayfin Loan Agreement Delayed Draw Term Loan"
                            }
                        }
                    },
                "localname":  "HayfinLoanAgreementDelayedDrawTermLoanMember",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_HayfinLoanAgreementTermLoanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Hayfin Loan Agreement Term Loan [Member]",
                            "label":  "Hayfin Loan Agreement Term Loan [Member]",
                            "terseLabel":  "Hayfin Loan Agreement Term Loan"
                            }
                        }
                    },
                "localname":  "HayfinLoanAgreementTermLoanMember",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x [Member]",
                            "label":  "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x [Member]",
                            "terseLabel":  "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x"
                            }
                        }
                    },
                "localname":  "HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x [Member]",
                            "label":  "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x [Member]",
                            "terseLabel":  "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x"
                            }
                        }
                    },
                "localname":  "HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_InvestigationRestatementandRelated":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Investigation, Restatement and Related",
                            "label":  "Investigation, Restatement and Related",
                            "terseLabel":  "Investigation, restatement and related"
                            }
                        }
                    },
                "localname":  "InvestigationRestatementandRelated",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_LeaseRightOfUseAssetAndLiability":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lease, Right Of Use Asset And Liability",
                            "label":  "Lease, Right Of Use Asset And Liability",
                            "terseLabel":  "Lease right of use asset and liability"
                            }
                        }
                    },
                "localname":  "LeaseRightOfUseAssetAndLiability",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaid":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid",
                            "label":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid",
                            "totalLabel":  "Total lease payments"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaid",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidAfterYearFive":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  7.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaid",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, After Year Five",
                            "label":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, After Year Five",
                            "totalLabel":  "Thereafter"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidAfterYearFive",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidRemainderOfFiscalYear":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaid",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, Remainder Of Fiscal Year",
                            "label":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, Remainder Of Fiscal Year",
                            "totalLabel":  "2021 (excluding the three months ended March 31, 2021)"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidRemainderOfFiscalYear",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearFive":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  4.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaid",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, Year Five",
                            "label":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, Year Five",
                            "totalLabel":  "2026"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearFive",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearFour":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  6.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaid",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, Year Four",
                            "label":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, Year Four",
                            "totalLabel":  "2025"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearFour",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearOne":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaid",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, Year One",
                            "label":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, Year One",
                            "totalLabel":  "2022"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearOne",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearThree":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  5.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaid",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, Year Three",
                            "label":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, Year Three",
                            "totalLabel":  "2024"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearThree",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearTwo":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  3.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaid",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, Year Two",
                            "label":  "Lessee, Operating Lease And Financing Lease, Liability, To Be Paid, Year Two",
                            "totalLabel":  "2023"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearTwo",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityUndiscountedExcessAmount":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  2.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaid",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lessee, Operating Lease And Financing Lease, Liability, Undiscounted Excess Amount",
                            "label":  "Lessee, Operating Lease And Financing Lease, Liability, Undiscounted Excess Amount",
                            "negatedTotalLabel":  "Less: imputed interest"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseAndFinancingLeaseLiabilityUndiscountedExcessAmount",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_LongTermDebtMaturityAfterYearFour":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Long-Term Debt, Maturity, after Year Four",
                            "label":  "Long-Term Debt, Maturity, after Year Four",
                            "terseLabel":  "Thereafter"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturityAfterYearFour",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_NotesReceivableForSaleOfPropertyAndEquipment":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Notes Receivable For Sale Of Property And Equipment",
                            "label":  "Notes Receivable For Sale Of Property And Equipment",
                            "terseLabel":  "Note receivable for sale of property and equipment"
                            }
                        }
                    },
                "localname":  "NotesReceivableForSaleOfPropertyAndEquipment",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_NumberOfSubleasedWarehouseSpaces":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of Subleased Warehouse Spaces",
                            "label":  "Number of Subleased Warehouse Spaces",
                            "terseLabel":  "Number of subleased warehouse spaces"
                            }
                        }
                    },
                "localname":  "NumberOfSubleasedWarehouseSpaces",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LeasesNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of Board Seats Elected by Temporary Equity Holders",
                            "label":  "Number of Board Seats Elected by Temporary Equity Holders",
                            "terseLabel":  "Number of board seats elected by Series B preferred stockholders"
                            }
                        }
                    },
                "localname":  "NumberofBoardSeatsElectedbyTemporaryEquityHolders",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "mdxg_NumberofDistributionChannels":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of Distribution Channels",
                            "label":  "Number of Distribution Channels",
                            "terseLabel":  "Number of primary distribution channels"
                            }
                        }
                    },
                "localname":  "NumberofDistributionChannels",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/RevenueDatabyCustomerTypeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "mdxg_OperatingLeaseAndFinanceLeaseLiability":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  1.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaid",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating Lease And Finance Lease, Liability",
                            "label":  "Operating Lease And Finance Lease, Liability",
                            "totalLabel":  "Present value of lease liabilities"
                            }
                        }
                    },
                "localname":  "OperatingLeaseAndFinanceLeaseLiability",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating Lease And Financing Lease, Right-Of-Use-Asset",
                            "label":  "Operating Lease And Financing Lease, Right-Of-Use-Asset",
                            "terseLabel":  "Right of use asset"
                            }
                        }
                    },
                "localname":  "OperatingLeaseAndFinancingLeaseRightOfUseAsset",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_OperatingLeaseRightofuseAssetAmortization":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating Lease, Right-of-use Asset, Amortization",
                            "label":  "Operating Lease, Right-of-use Asset, Amortization",
                            "terseLabel":  "Non-cash lease expenses"
                            }
                        }
                    },
                "localname":  "OperatingLeaseRightofuseAssetAmortization",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_PatentsinProcessMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Patents in Process",
                            "label":  "Patents in Process [Member]",
                            "terseLabel":  "Patents in process"
                            }
                        }
                    },
                "localname":  "PatentsinProcessMember",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_PaymentsforApplicationCostsPatent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Payments for Application Costs, Patent",
                            "label":  "Payments for Application Costs, Patent",
                            "negatedTerseLabel":  "Patent application costs"
                            }
                        }
                    },
                "localname":  "PaymentsforApplicationCostsPatent",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021 [Member]",
                            "label":  "Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021 [Member]",
                            "terseLabel":  "Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021"
                            }
                        }
                    },
                "localname":  "PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_ProceedsfromIssuanceofTemporaryEquity":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Proceeds from Issuance of Temporary Equity",
                            "label":  "Proceeds from Issuance of Temporary Equity",
                            "terseLabel":  "Proceeds from issuance of temporary equity"
                            }
                        }
                    },
                "localname":  "ProceedsfromIssuanceofTemporaryEquity",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_ScheduleOfDepreciationTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule Of Depreciation",
                            "label":  "Schedule Of Depreciation [Table Text Block]",
                            "terseLabel":  "Schedule of Depreciation Expense"
                            }
                        }
                    },
                "localname":  "ScheduleOfDepreciationTableTextBlock",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "mdxg_ScheduleofDebtIssuanceCostsTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of Debt Issuance Costs [Table Text Block]",
                            "label":  "Schedule of Debt Issuance Costs [Table Text Block]",
                            "terseLabel":  "Schedule of Debt Issuance Costs"
                            }
                        }
                    },
                "localname":  "ScheduleofDebtIssuanceCostsTableTextBlock",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "mdxg_ScheduleofInterestExpenseTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of Interest Expense [Table Text Block]",
                            "label":  "Schedule of Interest Expense [Table Text Block]",
                            "terseLabel":  "Schedule of Interest Expense"
                            }
                        }
                    },
                "localname":  "ScheduleofInterestExpenseTableTextBlock",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "mdxg_TemporaryEquityAccretedbutUnrecordedDividends":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails":  {
                        "order":  1.0,
                        "parentTag":  "mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Temporary Equity, Accreted but Unrecorded Dividends",
                            "label":  "Temporary Equity, Accreted but Unrecorded Dividends",
                            "terseLabel":  "Series B Preferred convertible Stock, dividends accrued but not recorded for the period",
                            "verboseLabel":  "Accumulated dividend on Series B Convertible Preferred Stock"
                            }
                        }
                    },
                "localname":  "TemporaryEquityAccretedbutUnrecordedDividends",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails",
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails":  {
                        "order":  2.0,
                        "parentTag":  "mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Temporary Equity, Accretion of Increasing-rate Dividend Feature",
                            "label":  "Temporary Equity, Accretion of Increasing-rate Dividend Feature",
                            "terseLabel":  "Accretion of increasing-rate dividend feature"
                            }
                        }
                    },
                "localname":  "TemporaryEquityAccretionofIncreasingrateDividendFeature",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_TemporaryEquityConversionPricePerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Temporary Equity, Conversion Price Per Share",
                            "label":  "Temporary Equity, Conversion Price Per Share",
                            "terseLabel":  "Series B preferred stock, conversion price (in dollars per share)"
                            }
                        }
                    },
                "localname":  "TemporaryEquityConversionPricePerShare",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "mdxg_TemporaryEquityConversionRatio":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Temporary Equity, Conversion Ratio",
                            "label":  "Temporary Equity, Conversion Ratio",
                            "terseLabel":  "Conversion ratio of Series B preferred stock to common stock"
                            }
                        }
                    },
                "localname":  "TemporaryEquityConversionRatio",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "pureItemType"
                },
            "mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger",
                            "label":  "Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger",
                            "terseLabel":  "Series B preferred stock, minimum percentage of conversion stock price to trigger conversion (percent)"
                            }
                        }
                    },
                "localname":  "TemporaryEquityConversionThresholdPercentageofStockPriceTrigger",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger on Date of Conversion",
                            "label":  "Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger on Date of Conversion",
                            "terseLabel":  "Series B preferred stock, minimum percentage of conversion stock price on conversion date (percent)"
                            }
                        }
                    },
                "localname":  "TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "mdxg_TemporaryEquityConversionThresholdTradingDays":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Temporary Equity, Conversion, Threshold Trading Days",
                            "label":  "Temporary Equity, Conversion, Threshold Trading Days",
                            "terseLabel":  "Number of trading days within consecutive day trading period common stock must exceed trigger conversion price"
                            }
                        }
                    },
                "localname":  "TemporaryEquityConversionThresholdTradingDays",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "mdxg_TemporaryEquityDividendRatePercentage":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Temporary Equity, Dividend Rate, Percentage",
                            "label":  "Temporary Equity, Dividend Rate, Percentage",
                            "terseLabel":  "Series B convertible stock, cumulative dividend (percent)"
                            }
                        }
                    },
                "localname":  "TemporaryEquityDividendRatePercentage",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "mdxg_TemporaryEquityIncreasingrateDividendFeature":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Temporary Equity, Increasing-rate Dividend Feature",
                            "label":  "Temporary Equity, Increasing-rate Dividend Feature",
                            "terseLabel":  "Series B preferred stock, increasing-rate dividend feature"
                            }
                        }
                    },
                "localname":  "TemporaryEquityIncreasingrateDividendFeature",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Temporary Equity, Maximum Voting Stock Percentage on As-converted Basis",
                            "label":  "Temporary Equity, Maximum Voting Stock Percentage on As-converted Basis",
                            "terseLabel":  "Series B preferred stock, maximum voting stock percentage on an as-converted basis (percent)"
                            }
                        }
                    },
                "localname":  "TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "mdxg_TemporaryEquitySharesIssueduponConversion":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Temporary Equity, Shares Issued upon Conversion",
                            "label":  "Temporary Equity, Shares Issued upon Conversion",
                            "terseLabel":  "Series B Preferred convertible stock, shares issuable upon conversion (in shares)"
                            }
                        }
                    },
                "localname":  "TemporaryEquitySharesIssueduponConversion",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "mdxg_TemporaryEquityThresholdConsecutiveTradingDays":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Temporary Equity, Threshold Consecutive Trading Days",
                            "label":  "Temporary Equity, Threshold Consecutive Trading Days",
                            "terseLabel":  "Series B preferred stock, threshold number of consecutive trading days"
                            }
                        }
                    },
                "localname":  "TemporaryEquityThresholdConsecutiveTradingDays",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "mdxg_TermLoanAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Term Loan Agreement [Member]",
                            "label":  "Term Loan Agreement [Member]",
                            "terseLabel":  "BT Term Loan"
                            }
                        }
                    },
                "localname":  "TermLoanAgreementMember",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "mdxg_TotalNetLeverageRatio":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total Net Leverage Ratio",
                            "label":  "Total Net Leverage Ratio",
                            "terseLabel":  "Total net leverage ratio"
                            }
                        }
                    },
                "localname":  "TotalNetLeverageRatio",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "pureItemType"
                },
            "mdxg_TypicalPaymentPeriodforCustomers":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Typical Payment Period for Customers",
                            "label":  "Typical Payment Period for Customers",
                            "terseLabel":  "Typical payment period for customers"
                            }
                        }
                    },
                "localname":  "TypicalPaymentPeriodforCustomers",
                "nsuri":  "http://mimedx.com/20210331",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "srt_MaximumMember":  {
                "auth_ref":  [
                    "r268",
                    "r270",
                    "r367",
                    "r368",
                    "r369",
                    "r370",
                    "r371",
                    "r372",
                    "r373",
                    "r405",
                    "r406"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Maximum [Member]",
                            "terseLabel":  "Maximum"
                            }
                        }
                    },
                "localname":  "MaximumMember",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MinimumMember":  {
                "auth_ref":  [
                    "r268",
                    "r270",
                    "r367",
                    "r368",
                    "r369",
                    "r370",
                    "r371",
                    "r372",
                    "r373",
                    "r405",
                    "r406"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Minimum [Member]",
                            "terseLabel":  "Minimum"
                            }
                        }
                    },
                "localname":  "MinimumMember",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RangeAxis":  {
                "auth_ref":  [
                    "r267",
                    "r268",
                    "r270",
                    "r367",
                    "r368",
                    "r369",
                    "r370",
                    "r371",
                    "r372",
                    "r373",
                    "r405",
                    "r406"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Axis]",
                            "terseLabel":  "Statistical Measurement [Axis]"
                            }
                        }
                    },
                "localname":  "RangeAxis",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RangeMember":  {
                "auth_ref":  [
                    "r267",
                    "r268",
                    "r270",
                    "r367",
                    "r368",
                    "r369",
                    "r370",
                    "r371",
                    "r372",
                    "r373",
                    "r405",
                    "r406"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Domain]",
                            "terseLabel":  "Statistical Measurement [Domain]"
                            }
                        }
                    },
                "localname":  "RangeMember",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ScenarioForecastMember":  {
                "auth_ref":  [
                    "r269"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Forecast [Member]",
                            "terseLabel":  "Forecast"
                            }
                        }
                    },
                "localname":  "ScenarioForecastMember",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ScenarioUnspecifiedDomain":  {
                "auth_ref":  [
                    "r269"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Scenario [Domain]",
                            "terseLabel":  "Scenario [Domain]"
                            }
                        }
                    },
                "localname":  "ScenarioUnspecifiedDomain",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_StatementScenarioAxis":  {
                "auth_ref":  [
                    "r224",
                    "r269",
                    "r365"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Scenario [Axis]",
                            "terseLabel":  "Scenario [Axis]"
                            }
                        }
                    },
                "localname":  "StatementScenarioAxis",
                "nsuri":  "http://fasb.org/srt/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Policies [Abstract]",
                            "terseLabel":  "Accounting Policies [Abstract]"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountingStandardsUpdate201409Member":  {
                "auth_ref":  [
                    "r265"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
                            "label":  "Accounting Standards Update 2014-09 [Member]",
                            "terseLabel":  "Accounting Standards Update 2014-09"
                            }
                        }
                    },
                "localname":  "AccountingStandardsUpdate201409Member",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r39"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
                            "label":  "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
                            "terseLabel":  "Accrued Expenses"
                            }
                        }
                    },
                "localname":  "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/AccruedExpenses"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_AccountsPayableCurrent":  {
                "auth_ref":  [
                    "r38"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accounts Payable, Current",
                            "verboseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "AccountsPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsReceivableNetCurrent":  {
                "auth_ref":  [
                    "r4",
                    "r23",
                    "r173",
                    "r174"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
                            "label":  "Accounts Receivable, after Allowance for Credit Loss, Current",
                            "terseLabel":  "Accounts receivable, net"
                            }
                        }
                    },
                "localname":  "AccountsReceivableNetCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r41"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/AccruedExpensesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.  Examples include taxes, interest, rent and utilities.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Liabilities, Current",
                            "terseLabel":  "Accrued expenses",
                            "totalLabel":  "Total"
                            }
                        }
                    },
                "localname":  "AccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/AccruedExpensesDetails",
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r386",
                    "r400"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/AccruedExpensesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
                            "label":  "Accrued Professional Fees",
                            "terseLabel":  "Legal costs"
                            }
                        }
                    },
                "localname":  "AccruedProfessionalFeesCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/AccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedSalesCommissionCurrent":  {
                "auth_ref":  [
                    "r8",
                    "r9",
                    "r41"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/AccruedExpensesDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Sales Commission, Current",
                            "terseLabel":  "Commissions to sales agents"
                            }
                        }
                    },
                "localname":  "AccruedSalesCommissionCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/AccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r36",
                    "r215"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_PropertyPlantAndEquipmentNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
                            "label":  "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
                            "negatedTerseLabel":  "Less accumulated depreciation"
                            }
                        }
                    },
                "localname":  "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapital":  {
                "auth_ref":  [
                    "r24",
                    "r301"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.  Includes adjustments to additional paid in capital.  Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees.  Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock.  For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock.  For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
                            "label":  "Additional Paid in Capital",
                            "terseLabel":  "Additional paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapital",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "auth_ref":  [
                    "r101",
                    "r102",
                    "r103",
                    "r298",
                    "r299",
                    "r300"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
                            "label":  "Additional Paid-in Capital [Member]",
                            "terseLabel":  "Additional Paid-in Capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis":  {
                "auth_ref":  [
                    "r104",
                    "r105",
                    "r106",
                    "r107",
                    "r183",
                    "r184",
                    "r185",
                    "r186",
                    "r187",
                    "r188",
                    "r294",
                    "r295",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r309",
                    "r310",
                    "r311",
                    "r312",
                    "r376",
                    "r377",
                    "r378",
                    "r407",
                    "r408",
                    "r409",
                    "r410",
                    "r411",
                    "r412",
                    "r413",
                    "r414",
                    "r415",
                    "r416",
                    "r417",
                    "r418"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by amendment to accounting standards.",
                            "label":  "Accounting Standards Update [Axis]",
                            "terseLabel":  "Adjustments for New Accounting Pronouncements [Axis]"
                            }
                        }
                    },
                "localname":  "AdjustmentsForNewAccountingPronouncementsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
                            "label":  "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
                            "negatedTerseLabel":  "Shares repurchased for tax withholding"
                            }
                        }
                    },
                "localname":  "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings":  {
                "auth_ref":  [
                    "r238",
                    "r245"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.",
                            "label":  "Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings",
                            "negatedTerseLabel":  "Deemed dividends",
                            "verboseLabel":  "Deemed dividends"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
                    "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Adjustments to reconcile net loss to net cash flows used in operating activities:"
                            }
                        }
                    },
                "localname":  "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables":  {
                "auth_ref":  [
                    "r176"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.",
                            "label":  "Allowance for Doubtful Accounts, Premiums and Other Receivables",
                            "negatedTerseLabel":  "Allowance for doubtful accounts"
                            }
                        }
                    },
                "localname":  "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfDebtDiscountPremium":  {
                "auth_ref":  [
                    "r66",
                    "r80",
                    "r343"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_InterestExpenseDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments.  Excludes amortization of financing costs.  Alternate captions include noncash interest expense.",
                            "label":  "Amortization of Debt Discount (Premium)",
                            "terseLabel":  "Accretion of original issue discount"
                            }
                        }
                    },
                "localname":  "AmortizationOfDebtDiscountPremium",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfFinancingCosts":  {
                "auth_ref":  [
                    "r62",
                    "r80",
                    "r345"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_InterestExpenseDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense attributable to debt issuance costs.",
                            "label":  "Amortization of Debt Issuance Costs",
                            "terseLabel":  "Amortization of deferred financing costs"
                            }
                        }
                    },
                "localname":  "AmortizationOfFinancingCosts",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfFinancingCostsAndDiscounts":  {
                "auth_ref":  [
                    "r80",
                    "r345"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
                            "label":  "Amortization of Debt Issuance Costs and Discounts",
                            "terseLabel":  "Amortization of deferred financing costs"
                            }
                        }
                    },
                "localname":  "AmortizationOfFinancingCostsAndDiscounts",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfIntangibleAssets":  {
                "auth_ref":  [
                    "r80",
                    "r199",
                    "r206"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  16.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.  As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
                            "label":  "Amortization of Intangible Assets",
                            "terseLabel":  "Amortization of intangible assets",
                            "verboseLabel":  "Amortization expense"
                            }
                        }
                    },
                "localname":  "AmortizationOfIntangibleAssets",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
                    "http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":  {
                "auth_ref":  [
                    "r128"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
                            "terseLabel":  "Antidilutive securities excluded from computation of earnings per share (in shares)"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis":  {
                "auth_ref":  [
                    "r128"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of antidilutive security.",
                            "label":  "Antidilutive Securities [Axis]",
                            "terseLabel":  "Antidilutive Securities [Axis]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
                            "terseLabel":  "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AntidilutiveSecuritiesNameDomain":  {
                "auth_ref":  [
                    "r128"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
                            "label":  "Antidilutive Securities, Name [Domain]",
                            "terseLabel":  "Antidilutive Securities, Name [Domain]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AssetRetirementObligationAccretionExpense":  {
                "auth_ref":  [
                    "r218",
                    "r219"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of accretion expense recognized during the period that is associated with an asset retirement obligation.  Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.",
                            "label":  "Asset Retirement Obligation, Accretion Expense",
                            "terseLabel":  "Accretion of asset retirement obligation"
                            }
                        }
                    },
                "localname":  "AssetRetirementObligationAccretionExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_Assets":  {
                "auth_ref":  [
                    "r95",
                    "r154",
                    "r158",
                    "r164",
                    "r182",
                    "r324",
                    "r327",
                    "r334",
                    "r381",
                    "r394"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets",
                            "totalLabel":  "Total assets"
                            }
                        }
                    },
                "localname":  "Assets",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets [Abstract]",
                            "terseLabel":  "ASSETS"
                            }
                        }
                    },
                "localname":  "AssetsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsCurrent":  {
                "auth_ref":  [
                    "r5",
                    "r6",
                    "r57",
                    "r95",
                    "r182",
                    "r324",
                    "r327",
                    "r334"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer).  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets, Current",
                            "totalLabel":  "Total current assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets, Current [Abstract]",
                            "terseLabel":  "Current assets:"
                            }
                        }
                    },
                "localname":  "AssetsCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AwardTypeAxis":  {
                "auth_ref":  [
                    "r273",
                    "r292"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of award under share-based payment arrangement.",
                            "label":  "Award Type [Axis]",
                            "terseLabel":  "Award Type [Axis]"
                            }
                        }
                    },
                "localname":  "AwardTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BalanceSheetLocationAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by location on balance sheet (statement of financial position).",
                            "label":  "Balance Sheet Location [Axis]",
                            "terseLabel":  "Balance Sheet Location [Axis]"
                            }
                        }
                    },
                "localname":  "BalanceSheetLocationAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BalanceSheetLocationDomain":  {
                "auth_ref":  [
                    "r330",
                    "r331"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Location in the balance sheet (statement of financial position).",
                            "label":  "Balance Sheet Location [Domain]",
                            "terseLabel":  "Balance Sheet Location [Domain]"
                            }
                        }
                    },
                "localname":  "BalanceSheetLocationDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_BasisOfAccountingPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
                            "label":  "Basis of Accounting, Policy [Policy Text Block]",
                            "terseLabel":  "Basis of Presentation"
                            }
                        }
                    },
                "localname":  "BasisOfAccountingPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CapitalExpendituresIncurredButNotYetPaid":  {
                "auth_ref":  [
                    "r85",
                    "r86",
                    "r87"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Future cash outflow to pay for purchases of fixed assets that have occurred.",
                            "label":  "Capital Expenditures Incurred but Not yet Paid",
                            "terseLabel":  "Purchases of equipment in accounts payable"
                            }
                        }
                    },
                "localname":  "CapitalExpendituresIncurredButNotYetPaid",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r2",
                    "r34",
                    "r82"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash and Cash Equivalents, at Carrying Value",
                            "terseLabel":  "Cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsPolicyTextBlock":  {
                "auth_ref":  [
                    "r13",
                    "r83",
                    "r91"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents.  Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
                            "label":  "Cash and Cash Equivalents, Policy [Policy Text Block]",
                            "terseLabel":  "Cash and Cash Equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":  {
                "auth_ref":  [
                    "r75",
                    "r82",
                    "r88"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage.  Excludes amount for disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
                            "periodEndLabel":  "Cash and cash equivalents, end of period",
                            "periodStartLabel":  "Cash and cash equivalents, beginning of period"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":  {
                "auth_ref":  [
                    "r75",
                    "r335"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
                            "totalLabel":  "Net change in cash"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
                            "terseLabel":  "Non-cash activities:"
                            }
                        }
                    },
                "localname":  "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CashFlowSupplementalDisclosuresTextBlock":  {
                "auth_ref":  [
                    "r89"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period.  Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Cash Flow, Supplemental Disclosures [Text Block]",
                            "terseLabel":  "Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities"
                            }
                        }
                    },
                "localname":  "CashFlowSupplementalDisclosuresTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ClassOfStockDomain":  {
                "auth_ref":  [
                    "r93",
                    "r95",
                    "r120",
                    "r121",
                    "r122",
                    "r125",
                    "r127",
                    "r138",
                    "r139",
                    "r140",
                    "r182",
                    "r334"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share of stock differentiated by the voting rights the holder receives.  Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
                            "label":  "Class of Stock [Domain]",
                            "terseLabel":  "Class of Stock [Domain]"
                            }
                        }
                    },
                "localname":  "ClassOfStockDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ClassOfStockLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Class of Stock [Line Items]",
                            "terseLabel":  "Class of Stock [Line Items]"
                            }
                        }
                    },
                "localname":  "ClassOfStockLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingencies":  {
                "auth_ref":  [
                    "r46",
                    "r223",
                    "r387",
                    "r399"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
                            "label":  "Commitments and Contingencies",
                            "terseLabel":  "Commitments and contingencies (Note 13)"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingencies",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and Contingencies Disclosure [Abstract]",
                            "terseLabel":  "Commitments and Contingencies Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r220",
                    "r221",
                    "r222",
                    "r226"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for commitments and contingencies.",
                            "label":  "Commitments and Contingencies Disclosure [Text Block]",
                            "terseLabel":  "Contractual Commitments and Contingencies"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/ContractualCommitmentsandContingencies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CommonStockMember":  {
                "auth_ref":  [
                    "r101",
                    "r102"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock that is subordinate to all other stock of the issuer.",
                            "label":  "Common Stock [Member]",
                            "terseLabel":  "Common Stock Issued"
                            }
                        }
                    },
                "localname":  "CommonStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r22"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of common stock.",
                            "label":  "Common Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Common stock, par value (in dollars per share)"
                            }
                        }
                    },
                "localname":  "CommonStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_CommonStockSharesAuthorized":  {
                "auth_ref":  [
                    "r22"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Common Stock, Shares Authorized",
                            "terseLabel":  "Common stock, shares authorized (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesIssued":  {
                "auth_ref":  [
                    "r22"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury.",
                            "label":  "Common Stock, Shares, Issued",
                            "terseLabel":  "Common stock, shares issued (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "auth_ref":  [
                    "r22",
                    "r238"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation.",
                            "label":  "Common Stock, Shares, Outstanding",
                            "terseLabel":  "Common stock, shares outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockValue":  {
                "auth_ref":  [
                    "r22"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Common Stock, Value, Issued",
                            "terseLabel":  "Common stock; $0.001 par value; 187,500,000 shares authorized; 112,703,926 issued and 111,620,629 outstanding at March\u00a031, 2021 and 112,703,926 issued and 110,930,243 outstanding at December\u00a031, 2020"
                            }
                        }
                    },
                "localname":  "CommonStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConsolidationPolicyTextBlock":  {
                "auth_ref":  [
                    "r91",
                    "r326"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
                            "label":  "Consolidation, Policy [Policy Text Block]",
                            "terseLabel":  "Principles of Consolidation"
                            }
                        }
                    },
                "localname":  "ConsolidationPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConstructionInProgressMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Structure or a modification to a structure under construction.  Includes recently completed structures or modifications to structures that have not been placed into service.",
                            "label":  "Construction in Progress [Member]",
                            "terseLabel":  "Construction in progress"
                            }
                        }
                    },
                "localname":  "ConstructionInProgressMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ContractWithCustomerAssetNetCurrent":  {
                "auth_ref":  [
                    "r249",
                    "r250",
                    "r261"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
                            "label":  "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
                            "terseLabel":  "Deferred cost of sales"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerAssetNetCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ContractWithCustomerRefundLiabilityCurrent":  {
                "auth_ref":  [
                    "r262"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/AccruedExpensesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.",
                            "label":  "Contract with Customer, Refund Liability, Current",
                            "terseLabel":  "Estimated returns"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerRefundLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/AccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ContractWithCustomerSalesChannelAxis":  {
                "auth_ref":  [
                    "r260",
                    "r263"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by sales channel for delivery of good or service in contract with customer.",
                            "label":  "Contract with Customer, Sales Channel [Axis]",
                            "terseLabel":  "Contract with Customer, Sales Channel [Axis]"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerSalesChannelAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/RevenueDatabyCustomerTypeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ContractWithCustomerSalesChannelDomain":  {
                "auth_ref":  [
                    "r260",
                    "r263"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sales channel for delivery of good or service in contract with customer.  Includes, but is not limited to, directly to consumer and through intermediary.",
                            "label":  "Contract with Customer, Sales Channel [Domain]",
                            "terseLabel":  "Contract with Customer, Sales Channel [Domain]"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerSalesChannelDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/RevenueDatabyCustomerTypeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CostOfGoodsAndServicesSold":  {
                "auth_ref":  [
                    "r64",
                    "r374"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_GrossProfit",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period.  This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
                            "label":  "Cost of Goods and Services Sold",
                            "terseLabel":  "Cost of sales"
                            }
                        }
                    },
                "localname":  "CostOfGoodsAndServicesSold",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
                    "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt Disclosure [Abstract]",
                            "terseLabel":  "Debt Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "DebtDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtDisclosureTextBlock":  {
                "auth_ref":  [
                    "r232"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
                            "label":  "Debt Disclosure [Text Block]",
                            "terseLabel":  "Long Term Debt"
                            }
                        }
                    },
                "localname":  "DebtDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebt"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DebtInstrumentAxis":  {
                "auth_ref":  [
                    "r16",
                    "r17",
                    "r18",
                    "r382",
                    "r383",
                    "r393"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
                            "label":  "Debt Instrument [Axis]",
                            "terseLabel":  "Debt Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
                            "label":  "Debt Instrument, Basis Spread on Variable Rate",
                            "terseLabel":  "Debt instrument, basis spread on variable rate"
                            }
                        }
                    },
                "localname":  "DebtInstrumentBasisSpreadOnVariableRate1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentCarryingAmount":  {
                "auth_ref":  [
                    "r18",
                    "r229",
                    "r383",
                    "r393"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt.  Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
                            "label":  "Long-term Debt, Gross",
                            "terseLabel":  "Outstanding principal"
                            }
                        }
                    },
                "localname":  "DebtInstrumentCarryingAmount",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentFaceAmount":  {
                "auth_ref":  [
                    "r344",
                    "r346"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face (par) amount of debt instrument at time of issuance.",
                            "label":  "Debt Instrument, Face Amount",
                            "terseLabel":  "Principal issued"
                            }
                        }
                    },
                "localname":  "DebtInstrumentFaceAmount",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentInterestRateDuringPeriod":  {
                "auth_ref":  [
                    "r43",
                    "r344"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The average effective interest rate during the reporting period.",
                            "label":  "Debt Instrument, Interest Rate During Period",
                            "terseLabel":  "Interest rate at issuance (percent)"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateDuringPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentInterestRateIncreaseDecrease":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incremental percentage increase (decrease) in the stated rate on a debt instrument.",
                            "label":  "Debt Instrument, Interest Rate, Increase (Decrease)",
                            "terseLabel":  "Increase in interest rate (percent)"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateIncreaseDecrease",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Debt Instrument [Line Items]",
                            "terseLabel":  "Debt Instrument [Line Items]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentNameDomain":  {
                "auth_ref":  [
                    "r44"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
                            "label":  "Debt Instrument, Name [Domain]",
                            "terseLabel":  "Debt Instrument, Name [Domain]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DebtInstrumentPeriodicPayment":  {
                "auth_ref":  [
                    "r44",
                    "r391"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the required periodic payments including both interest and principal payments.",
                            "label":  "Debt Instrument, Periodic Payment",
                            "terseLabel":  "Quarterly installments"
                            }
                        }
                    },
                "localname":  "DebtInstrumentPeriodicPayment",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentTable":  {
                "auth_ref":  [
                    "r44",
                    "r97",
                    "r239",
                    "r242",
                    "r243",
                    "r244",
                    "r343",
                    "r344",
                    "r346",
                    "r392"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
                            "label":  "Schedule of Long-term Debt Instruments [Table]",
                            "terseLabel":  "Schedule of Long-term Debt Instruments [Table]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentUnamortizedDiscount":  {
                "auth_ref":  [
                    "r343",
                    "r346"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after accumulated amortization, of debt discount.",
                            "label":  "Debt Instrument, Unamortized Discount",
                            "negatedLabel":  "Original issue discount",
                            "verboseLabel":  "Original issue discount"
                            }
                        }
                    },
                "localname":  "DebtInstrumentUnamortizedDiscount",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredFinanceCostsGross":  {
                "auth_ref":  [
                    "r345"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, before accumulated amortization, of debt issuance costs.  Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
                            "label":  "Debt Issuance Costs, Gross",
                            "verboseLabel":  "Deferred financing costs"
                            }
                        }
                    },
                "localname":  "DeferredFinanceCostsGross",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredFinanceCostsNet":  {
                "auth_ref":  [
                    "r37",
                    "r345"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after accumulated amortization, of debt issuance costs.  Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
                            "label":  "Debt Issuance Costs, Net",
                            "negatedLabel":  "Deferred financing costs"
                            }
                        }
                    },
                "localname":  "DeferredFinanceCostsNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_Depreciation":  {
                "auth_ref":  [
                    "r80",
                    "r213"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  12.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives.  Includes production and non-production related depreciation.",
                            "label":  "Depreciation",
                            "terseLabel":  "Depreciation",
                            "verboseLabel":  "Depreciation expense"
                            }
                        }
                    },
                "localname":  "Depreciation",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
                    "http://mimedx.com/role/PropertyandEquipmentDepreciationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock":  {
                "auth_ref":  [
                    "r302"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for share-based payment arrangement.",
                            "label":  "Share-based Payment Arrangement [Text Block]",
                            "terseLabel":  "Stock-based Compensation"
                            }
                        }
                    },
                "localname":  "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensation"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-based Payment Arrangement [Abstract]"
                            }
                        }
                    },
                "localname":  "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DividendsAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information about distribution of earnings to shareholders including, but not limited to, cash, property or capital stock.",
                            "label":  "Dividends [Axis]",
                            "terseLabel":  "Dividends [Axis]"
                            }
                        }
                    },
                "localname":  "DividendsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DividendsDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Distributions of earnings to shareholders including but not limited to cash, property or capital stock.",
                            "label":  "Dividends [Domain]",
                            "terseLabel":  "Dividends [Domain]"
                            }
                        }
                    },
                "localname":  "DividendsDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DividendsPayableLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Dividends Payable [Line Items]",
                            "terseLabel":  "Dividends Payable [Line Items]"
                            }
                        }
                    },
                "localname":  "DividendsPayableLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DividendsPayableTable":  {
                "auth_ref":  [
                    "r85"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A table that contains information regarding dividends that have been declared but not paid as of the financial reporting date.  This information may contain the amount, amount per share, declared date, and date to be paid.",
                            "label":  "Dividends Payable [Table]",
                            "terseLabel":  "Dividends Payable [Table]"
                            }
                        }
                    },
                "localname":  "DividendsPayableTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EarningsPerShareAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Earnings Per Share [Abstract]",
                            "terseLabel":  "Earnings Per Share [Abstract]"
                            }
                        }
                    },
                "localname":  "EarningsPerShareAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EarningsPerShareBasic":  {
                "auth_ref":  [
                    "r61",
                    "r109",
                    "r110",
                    "r111",
                    "r112",
                    "r113",
                    "r117",
                    "r120",
                    "r125",
                    "r126",
                    "r127",
                    "r131",
                    "r132",
                    "r389",
                    "r403"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
                            "label":  "Earnings Per Share, Basic",
                            "netLabel":  "Basic net loss per common share (in dollars per share)",
                            "verboseLabel":  "Net loss per common share - basic (in dollars per share)"
                            }
                        }
                    },
                "localname":  "EarningsPerShareBasic",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerShareDiluted":  {
                "auth_ref":  [
                    "r61",
                    "r109",
                    "r110",
                    "r111",
                    "r112",
                    "r113",
                    "r120",
                    "r125",
                    "r126",
                    "r127",
                    "r131",
                    "r132",
                    "r389",
                    "r403"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
                            "label":  "Earnings Per Share, Diluted",
                            "terseLabel":  "Net loss per common share - diluted (in dollars per share)",
                            "verboseLabel":  "Diluted net (loss) income per common share (in dollars per share)"
                            }
                        }
                    },
                "localname":  "EarningsPerShareDiluted",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerShareTextBlock":  {
                "auth_ref":  [
                    "r128",
                    "r129",
                    "r130",
                    "r133"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for earnings per share.",
                            "label":  "Earnings Per Share [Text Block]",
                            "verboseLabel":  "Net Loss Per Common Share"
                            }
                        }
                    },
                "localname":  "EarningsPerShareTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShare"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateContinuingOperations":  {
                "auth_ref":  [
                    "r305"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Effective Income Tax Rate Reconciliation, Percent",
                            "terseLabel":  "Effective tax rate"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateContinuingOperations",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IncometaxesDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EmployeeRelatedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r41"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Employee-related Liabilities, Current",
                            "terseLabel":  "Accrued compensation"
                            }
                        }
                    },
                "localname":  "EmployeeRelatedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions":  {
                "auth_ref":  [
                    "r291"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cost to be recognized for option under share-based payment arrangement.",
                            "label":  "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
                            "terseLabel":  "Total unrecognized compensation expense"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeStockOptionMember":  {
                "auth_ref":  [
                    "r290"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
                            "label":  "Share-based Payment Arrangement, Option [Member]",
                            "verboseLabel":  "Outstanding Stock Options"
                            }
                        }
                    },
                "localname":  "EmployeeStockOptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EntityWideRevenueMajorCustomerLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Revenue, Major Customer [Line Items]",
                            "terseLabel":  "Revenue, Major Customer [Line Items]"
                            }
                        }
                    },
                "localname":  "EntityWideRevenueMajorCustomerLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/RevenueDatabyCustomerTypeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquipmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tangible personal property used to produce goods and services.",
                            "label":  "Equipment [Member]",
                            "terseLabel":  "Laboratory and clean room equipment"
                            }
                        }
                    },
                "localname":  "EquipmentMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity [Abstract]",
                            "terseLabel":  "Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "EquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquityComponentDomain":  {
                "auth_ref":  [
                    "r101",
                    "r102",
                    "r103",
                    "r105",
                    "r114",
                    "r116",
                    "r137",
                    "r186",
                    "r238",
                    "r245",
                    "r298",
                    "r299",
                    "r300",
                    "r311",
                    "r312",
                    "r336",
                    "r337",
                    "r338",
                    "r339",
                    "r340",
                    "r341",
                    "r409",
                    "r410",
                    "r411"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
                            "label":  "Equity Component [Domain]",
                            "terseLabel":  "Equity Component [Domain]"
                            }
                        }
                    },
                "localname":  "EquityComponentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FederalFundsEffectiveSwapRateMember":  {
                "auth_ref":  [
                    "r333"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
                            "label":  "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
                            "terseLabel":  "Fed Funds Effective Rate Overnight Index Swap Rate"
                            }
                        }
                    },
                "localname":  "FederalFundsEffectiveSwapRateMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FinanceLeaseInterestExpense":  {
                "auth_ref":  [
                    "r349",
                    "r353",
                    "r361"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of interest expense on finance lease liability.",
                            "label":  "Finance Lease, Interest Expense",
                            "terseLabel":  "Interest expense on finance lease"
                            }
                        }
                    },
                "localname":  "FinanceLeaseInterestExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesLeaseCostsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finance Lease, Liability, Payment, Due [Abstract]",
                            "terseLabel":  "Finance Leases"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilitiesPaymentsDueAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FinanceLeaseLiability":  {
                "auth_ref":  [
                    "r348",
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "mdxg_OperatingLeaseAndFinanceLeaseLiability",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from finance lease.",
                            "label":  "Finance Lease, Liability",
                            "terseLabel":  "Right of use liability",
                            "totalLabel":  "Right of use liability"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiability",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails",
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityCurrent":  {
                "auth_ref":  [
                    "r348"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiability",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
                            "label":  "Finance Lease, Liability, Current",
                            "terseLabel":  "Current right of use liability"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock":  {
                "auth_ref":  [
                    "r360"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of undiscounted cash flows of finance lease liability.  Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
                            "label":  "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
                            "terseLabel":  "Maturities of Financing Lease Liabilities"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityMaturityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FinanceLeaseLiabilityNoncurrent":  {
                "auth_ref":  [
                    "r348"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiability",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
                            "label":  "Finance Lease, Liability, Noncurrent",
                            "terseLabel":  "Noncurrent right of use liability"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDue":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
                            "label":  "Finance Lease, Liability, Payment, Due",
                            "totalLabel":  "Total lease payments"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidAfterYearFive",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finance Lease, Liability, to be Paid, after Year Five",
                            "terseLabel":  "Thereafter"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearOne",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finance Lease, Liability, to be Paid, Year One",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearFive",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finance Lease, Liability, to be Paid, Year Five",
                            "terseLabel":  "2026"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearFive",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearFour",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finance Lease, Liability, to be Paid, Year Four",
                            "terseLabel":  "2025"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearThree",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finance Lease, Liability, to be Paid, Year Three",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearTwo",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finance Lease, Liability, to be Paid, Year Two",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidRemainderOfFiscalYear",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
                            "label":  "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
                            "terseLabel":  "2021 (excluding the three months ended March 31, 2021)"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityUndiscountedExcessAmount",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
                            "label":  "Finance Lease, Liability, Undiscounted Excess Amount",
                            "negatedTerseLabel":  "Less: imputed interest"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityUndiscountedExcessAmount",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeasePrincipalPayments":  {
                "auth_ref":  [
                    "r350",
                    "r356"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow for principal payment on finance lease.",
                            "label":  "Finance Lease, Principal Payments",
                            "negatedTerseLabel":  "Principal payments on finance lease"
                            }
                        }
                    },
                "localname":  "FinanceLeasePrincipalPayments",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseRightOfUseAssetAmortization":  {
                "auth_ref":  [
                    "r349",
                    "r353",
                    "r361"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense attributable to right-of-use asset from finance lease.",
                            "label":  "Finance Lease, Right-of-Use Asset, Amortization",
                            "terseLabel":  "Depreciation expense on finance lease"
                            }
                        }
                    },
                "localname":  "FinanceLeaseRightOfUseAssetAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesLeaseCostsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization":  {
                "auth_ref":  [
                    "r347"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, before accumulated amortization, of right-of-use asset from finance lease.",
                            "label":  "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
                            "terseLabel":  "Right of use asset"
                            }
                        }
                    },
                "localname":  "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent":  {
                "auth_ref":  [
                    "r358",
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average discount rate for finance lease calculated at point in time.",
                            "label":  "Finance Lease, Weighted Average Discount Rate, Percent",
                            "terseLabel":  "Weighted-average discount rate"
                            }
                        }
                    },
                "localname":  "FinanceLeaseWeightedAverageDiscountRatePercent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1":  {
                "auth_ref":  [
                    "r357",
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Finance Lease, Weighted Average Remaining Lease Term",
                            "terseLabel":  "Weighted-average remaining lease term (years)"
                            }
                        }
                    },
                "localname":  "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization":  {
                "auth_ref":  [
                    "r205"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Finite-Lived Intangible Assets, Accumulated Amortization",
                            "negatedTerseLabel":  "Accumulated amortization"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAccumulatedAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths":  {
                "auth_ref":  [
                    "r207"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year One",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
                            "terseLabel":  "2021 (excluding the three months ended March 31, 2021)"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour":  {
                "auth_ref":  [
                    "r207"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
                            "terseLabel":  "2025"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree":  {
                "auth_ref":  [
                    "r207"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo":  {
                "auth_ref":  [
                    "r207"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "auth_ref":  [
                    "r200",
                    "r202",
                    "r205",
                    "r209",
                    "r375",
                    "r379"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by major type or class of finite-lived intangible assets.",
                            "label":  "Finite-Lived Intangible Assets by Major Class [Axis]",
                            "terseLabel":  "Finite-Lived Intangible Assets by Major Class [Axis]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsByMajorClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend":  {
                "auth_ref":  [
                    "r210"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of capitalized costs incurred in the period to renew or extend the term of a recognized finite-lived (amortizing and amortizable) intangible asset.",
                            "label":  "Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend",
                            "terseLabel":  "Capitalized patent costs"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
                            "terseLabel":  "Estimated future amortization expense [Abstract]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsGross":  {
                "auth_ref":  [
                    "r205",
                    "r379"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Finite-Lived Intangible Assets, Gross",
                            "terseLabel":  "Gross carrying amount"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsGross",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Finite-Lived Intangible Assets [Line Items]",
                            "terseLabel":  "Finite-Lived Intangible Assets [Line Items]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails",
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "auth_ref":  [
                    "r200",
                    "r204"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
                            "label":  "Finite-Lived Intangible Assets, Major Class Name [Domain]",
                            "terseLabel":  "Finite-Lived Intangible Assets, Major Class Name [Domain]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsMajorClassNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsNet":  {
                "auth_ref":  [
                    "r205",
                    "r375"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IntangibleAssetsNetExcludingGoodwill",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Finite-Lived Intangible Assets, Net",
                            "totalLabel":  "Net carrying amount"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails",
                    "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FurnitureAndFixturesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities.  Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
                            "label":  "Furniture and Fixtures [Member]",
                            "terseLabel":  "Furniture and equipment"
                            }
                        }
                    },
                "localname":  "FurnitureAndFixturesMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_GainLossOnSaleOfPropertyPlantEquipment":  {
                "auth_ref":  [
                    "r80"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
                            "label":  "Gain (Loss) on Disposition of Property Plant Equipment",
                            "negatedTerseLabel":  "Loss on fixed asset disposal"
                            }
                        }
                    },
                "localname":  "GainLossOnSaleOfPropertyPlantEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_Goodwill":  {
                "auth_ref":  [
                    "r192",
                    "r194",
                    "r380"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
                            "label":  "Goodwill",
                            "terseLabel":  "Goodwill"
                            }
                        }
                    },
                "localname":  "Goodwill",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Goodwill and Intangible Assets Disclosure [Abstract]",
                            "terseLabel":  "Goodwill and Intangible Assets Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "GoodwillAndIntangibleAssetsDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy":  {
                "auth_ref":  [
                    "r91",
                    "r196"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for goodwill.  This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
                            "label":  "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
                            "terseLabel":  "Goodwill"
                            }
                        }
                    },
                "localname":  "GoodwillAndIntangibleAssetsGoodwillPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_GoodwillImpairmentLoss":  {
                "auth_ref":  [
                    "r80",
                    "r193",
                    "r195",
                    "r197"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
                            "label":  "Goodwill, Impairment Loss",
                            "terseLabel":  "Goodwill impairment"
                            }
                        }
                    },
                "localname":  "GoodwillImpairmentLoss",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GrossProfit":  {
                "auth_ref":  [
                    "r63",
                    "r95",
                    "r154",
                    "r157",
                    "r160",
                    "r163",
                    "r166",
                    "r182",
                    "r334"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
                            "label":  "Gross Profit",
                            "terseLabel":  "Gross Profit",
                            "totalLabel":  "Gross profit"
                            }
                        }
                    },
                "localname":  "GrossProfit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
                    "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments":  {
                "auth_ref":  [
                    "r98",
                    "r154",
                    "r157",
                    "r160",
                    "r163",
                    "r166"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
                            "label":  "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
                            "totalLabel":  "Loss before income tax provision"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeStatementAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Statement [Abstract]",
                            "terseLabel":  "Income Statement [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeStatementAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Tax Disclosure [Abstract]",
                            "terseLabel":  "Income Tax Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxDisclosureTextBlock":  {
                "auth_ref":  [
                    "r306",
                    "r307",
                    "r308",
                    "r313",
                    "r315",
                    "r317",
                    "r318",
                    "r319"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for income taxes.  Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
                            "label":  "Income Tax Disclosure [Text Block]",
                            "verboseLabel":  "Income taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Incometaxes"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r96",
                    "r115",
                    "r116",
                    "r153",
                    "r304",
                    "r314",
                    "r316",
                    "r404"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Income Tax Expense (Benefit)",
                            "negatedTerseLabel":  "Income tax provision (expense) benefit"
                            }
                        }
                    },
                "localname":  "IncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
                    "http://mimedx.com/role/IncometaxesDetails",
                    "http://mimedx.com/role/NatureofBusinessDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxesPaid":  {
                "auth_ref":  [
                    "r76",
                    "r84"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
                            "label":  "Income Taxes Paid",
                            "terseLabel":  "Income taxes paid"
                            }
                        }
                    },
                "localname":  "IncomeTaxesPaid",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxesReceivable":  {
                "auth_ref":  [
                    "r50",
                    "r385",
                    "r401"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
                            "label":  "Income Taxes Receivable, Current",
                            "terseLabel":  "Income tax receivable"
                            }
                        }
                    },
                "localname":  "IncomeTaxesReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
                    "http://mimedx.com/role/NatureofBusinessDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsPayable":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  13.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
                            "label":  "Increase (Decrease) in Accounts Payable",
                            "terseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsPayable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsReceivable":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  17.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
                            "label":  "Increase (Decrease) in Accounts Receivable",
                            "negatedLabel":  "Accounts receivable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccruedLiabilities":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
                            "label":  "Increase (Decrease) in Accrued Liabilities",
                            "terseLabel":  "Accrued expenses"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccruedLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInDeferredCompensation":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.",
                            "label":  "Increase (Decrease) in Deferred Compensation",
                            "terseLabel":  "Accrued compensation"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInDeferredCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.",
                            "label":  "Increase (Decrease) in Income Taxes Receivable",
                            "negatedTerseLabel":  "Income taxes"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInIncomeTaxesReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInInventories":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
                            "label":  "Increase (Decrease) in Inventories",
                            "negatedTerseLabel":  "Inventory"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInInventories",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Operating Capital [Abstract]",
                            "terseLabel":  "Increase (decrease) in cash resulting from changes in:"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseDecreaseInOtherOperatingAssets":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  14.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in operating assets classified as other.",
                            "label":  "Increase (Decrease) in Other Operating Assets",
                            "negatedTerseLabel":  "Other assets"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOtherOperatingAssets",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in operating liabilities classified as other.",
                            "label":  "Increase (Decrease) in Other Operating Liabilities",
                            "terseLabel":  "Other liabilities"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOtherOperatingLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInPrepaidExpense":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  15.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
                            "label":  "Increase (Decrease) in Prepaid Expense",
                            "negatedTerseLabel":  "Prepaid expenses"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInPrepaidExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
                            "terseLabel":  "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInStockholdersEquityRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Increase (Decrease) in Temporary Equity [Roll Forward]",
                            "terseLabel":  "Increase (Decrease) in Temporary Equity [Roll Forward]"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInTemporaryEquityRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "auth_ref":  [
                    "r201",
                    "r208"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
                            "label":  "Indefinite-lived Intangible Assets [Axis]",
                            "terseLabel":  "Indefinite-lived Intangible Assets [Axis]"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Indefinite-lived Intangible Assets [Line Items]",
                            "terseLabel":  "Indefinite-lived Intangible Assets [Line Items]"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill":  {
                "auth_ref":  [
                    "r208"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IntangibleAssetsNetExcludingGoodwill",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
                            "label":  "Indefinite-lived Intangible Assets (Excluding Goodwill)",
                            "terseLabel":  "Gross carrying value, indefinite lived"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "auth_ref":  [
                    "r201",
                    "r208"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill.  A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
                            "label":  "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
                            "terseLabel":  "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_InsuranceSettlementsReceivable":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.",
                            "label":  "Insurance Settlements Receivable",
                            "terseLabel":  "Settlements indemnified by insurance"
                            }
                        }
                    },
                "localname":  "InsuranceSettlementsReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IntangibleAssetsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r212"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for all or part of the information related to intangible assets.",
                            "label":  "Intangible Assets Disclosure [Text Block]",
                            "verboseLabel":  "Intangible Assets"
                            }
                        }
                    },
                "localname":  "IntangibleAssetsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssets"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IntangibleAssetsGrossExcludingGoodwill":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before accumulated amortization of intangible assets, excluding goodwill.",
                            "label":  "Intangible Assets, Gross (Excluding Goodwill)",
                            "totalLabel":  "Intangible assets, gross carrying amount"
                            }
                        }
                    },
                "localname":  "IntangibleAssetsGrossExcludingGoodwill",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IntangibleAssetsNetExcludingGoodwill":  {
                "auth_ref":  [
                    "r198",
                    "r203"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
                            "label":  "Intangible Assets, Net (Excluding Goodwill)",
                            "terseLabel":  "Intangible assets, net",
                            "totalLabel":  "Intangible assets, net carrying amount"
                            }
                        }
                    },
                "localname":  "IntangibleAssetsNetExcludingGoodwill",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestExpenseDebt":  {
                "auth_ref":  [
                    "r66",
                    "r231"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
                            "label":  "Interest Expense, Debt",
                            "totalLabel":  "Total BT Term Loan interest expense"
                            }
                        }
                    },
                "localname":  "InterestExpenseDebt",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestExpenseDebtExcludingAmortization":  {
                "auth_ref":  [
                    "r68"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_InterestExpenseDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
                            "label":  "Interest Expense, Debt, Excluding Amortization",
                            "terseLabel":  "Interest on principal balance"
                            }
                        }
                    },
                "localname":  "InterestExpenseDebtExcludingAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestIncomeExpenseNet":  {
                "auth_ref":  [
                    "r390"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The net amount of operating interest income (expense).",
                            "label":  "Interest Income (Expense), Net",
                            "terseLabel":  "Interest expense, net"
                            }
                        }
                    },
                "localname":  "InterestIncomeExpenseNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPaid":  {
                "auth_ref":  [
                    "r84"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
                            "label":  "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
                            "terseLabel":  "Cash paid for interest"
                            }
                        }
                    },
                "localname":  "InterestPaid",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InventoryDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Inventory Disclosure [Abstract]",
                            "terseLabel":  "Inventory Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "InventoryDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_InventoryDisclosureTextBlock":  {
                "auth_ref":  [
                    "r191"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for inventory.  Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
                            "label":  "Inventory Disclosure [Text Block]",
                            "verboseLabel":  "Inventory"
                            }
                        }
                    },
                "localname":  "InventoryDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Inventory"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_InventoryFinishedGoods":  {
                "auth_ref":  [
                    "r51"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/InventoryDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_InventoryNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
                            "label":  "Inventory, Finished Goods, Gross",
                            "terseLabel":  "Finished goods"
                            }
                        }
                    },
                "localname":  "InventoryFinishedGoods",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/InventoryDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InventoryNet":  {
                "auth_ref":  [
                    "r3",
                    "r54"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/InventoryDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
                            "label":  "Inventory, Net",
                            "terseLabel":  "Inventory",
                            "totalLabel":  "Inventory"
                            }
                        }
                    },
                "localname":  "InventoryNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
                    "http://mimedx.com/role/InventoryDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InventoryPolicyTextBlock":  {
                "auth_ref":  [
                    "r11",
                    "r55",
                    "r91",
                    "r136",
                    "r189",
                    "r190",
                    "r191"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
                            "label":  "Inventory, Policy [Policy Text Block]",
                            "terseLabel":  "Inventories"
                            }
                        }
                    },
                "localname":  "InventoryPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_InventoryRawMaterials":  {
                "auth_ref":  [
                    "r53"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/InventoryDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_InventoryNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
                            "label":  "Inventory, Raw Materials, Gross",
                            "terseLabel":  "Raw materials"
                            }
                        }
                    },
                "localname":  "InventoryRawMaterials",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/InventoryDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InventoryWorkInProcess":  {
                "auth_ref":  [
                    "r52"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/InventoryDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_InventoryNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
                            "label":  "Inventory, Work in Process, Gross",
                            "terseLabel":  "Work in process"
                            }
                        }
                    },
                "localname":  "InventoryWorkInProcess",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/InventoryDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LeaseCostTableTextBlock":  {
                "auth_ref":  [
                    "r359"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of lessee's lease cost.  Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
                            "label":  "Lease, Cost [Table Text Block]",
                            "terseLabel":  "Lease Costs"
                            }
                        }
                    },
                "localname":  "LeaseCostTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LeaseholdImprovementsMember":  {
                "auth_ref":  [
                    "r214"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Additions or improvements to assets held under a lease arrangement.",
                            "label":  "Leasehold Improvements [Member]",
                            "terseLabel":  "Leasehold improvements"
                            }
                        }
                    },
                "localname":  "LeaseholdImprovementsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LeasesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Leases [Abstract]",
                            "terseLabel":  "Leases [Abstract]"
                            }
                        }
                    },
                "localname":  "LeasesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LeasesOperatingAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Leases, Operating [Abstract]",
                            "terseLabel":  "Operating Leases"
                            }
                        }
                    },
                "localname":  "LeasesOperatingAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LegalCostsPolicyTextBlock":  {
                "auth_ref":  [
                    "r90",
                    "r91",
                    "r225"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.",
                            "label":  "Legal Costs, Policy [Policy Text Block]",
                            "terseLabel":  "Patent Costs"
                            }
                        }
                    },
                "localname":  "LegalCostsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LesseeFinanceLeaseDescriptionAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lessee, Finance Lease, Description [Abstract]",
                            "terseLabel":  "Finance Leases"
                            }
                        }
                    },
                "localname":  "LesseeFinanceLeaseDescriptionAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LesseeFinanceLeasesTextBlock":  {
                "auth_ref":  [
                    "r362"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for finance leases of lessee.  Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
                            "label":  "Lessee, Finance Leases [Text Block]",
                            "terseLabel":  "Leases"
                            }
                        }
                    },
                "localname":  "LesseeFinanceLeasesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Leases"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LesseeLeasesPolicyTextBlock":  {
                "auth_ref":  [
                    "r351"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
                            "label":  "Lessee, Leases [Policy Text Block]",
                            "terseLabel":  "Leases"
                            }
                        }
                    },
                "localname":  "LesseeLeasesPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock":  {
                "auth_ref":  [
                    "r360"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability.  Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
                            "label":  "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
                            "terseLabel":  "Maturities of Operating Lease Liabilities"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid",
                            "totalLabel":  "Total lease payments"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidAfterYearFive",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
                            "terseLabel":  "Thereafter"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearOne",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year One",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearFive",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year Five",
                            "terseLabel":  "2026"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearFour",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year Four",
                            "terseLabel":  "2025"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearThree",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year Three",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidYearTwo",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year Two",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityToBePaidRemainderOfFiscalYear",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
                            "terseLabel":  "2021 (excluding the three months ended March 31, 2021)"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount":  {
                "auth_ref":  [
                    "r360"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "mdxg_LesseeOperatingLeaseAndFinancingLeaseLiabilityUndiscountedExcessAmount",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
                            "label":  "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
                            "negatedTerseLabel":  "Less: imputed interest"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseTermOfContract":  {
                "auth_ref":  [
                    "r352"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Lessee, Operating Lease, Term of Contract",
                            "terseLabel":  "Lessee expiration period (in years)"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseTermOfContract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_LesseeOperatingLeasesTextBlock":  {
                "auth_ref":  [
                    "r362"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for operating leases of lessee.  Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
                            "label":  "Lessee, Operating Leases [Text Block]",
                            "terseLabel":  "Leases"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeasesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Leases"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_Liabilities":  {
                "auth_ref":  [
                    "r40",
                    "r95",
                    "r159",
                    "r182",
                    "r325",
                    "r327",
                    "r328",
                    "r334"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized.  Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
                            "label":  "Liabilities",
                            "totalLabel":  "Total liabilities"
                            }
                        }
                    },
                "localname":  "Liabilities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "auth_ref":  [
                    "r28",
                    "r95",
                    "r182",
                    "r334",
                    "r384",
                    "r397"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
                            "label":  "Liabilities and Equity",
                            "totalLabel":  "Total liabilities, convertible preferred stock, and stockholders\u2019 deficit"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities and Equity [Abstract]",
                            "terseLabel":  "LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS\u2019 DEFICIT"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesCurrent":  {
                "auth_ref":  [
                    "r42",
                    "r95",
                    "r182",
                    "r325",
                    "r327",
                    "r328",
                    "r334"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
                            "label":  "Liabilities, Current",
                            "totalLabel":  "Total current liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities, Current [Abstract]",
                            "verboseLabel":  "Current liabilities:"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LicensingAgreementsMember":  {
                "auth_ref":  [
                    "r322"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
                            "label":  "Licensing Agreements [Member]",
                            "terseLabel":  "Licenses"
                            }
                        }
                    },
                "localname":  "LicensingAgreementsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LitigationReserve":  {
                "auth_ref":  [
                    "r46",
                    "r223"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
                            "label":  "Estimated Litigation Liability",
                            "terseLabel":  "Litigation liability"
                            }
                        }
                    },
                "localname":  "LitigationReserve",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LondonInterbankOfferedRateLIBORMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
                            "label":  "London Interbank Offered Rate (LIBOR) [Member]",
                            "terseLabel":  "London Interbank Offered Rate (LIBOR)"
                            }
                        }
                    },
                "localname":  "LondonInterbankOfferedRateLIBORMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LongTermDebt":  {
                "auth_ref":  [
                    "r18",
                    "r230",
                    "r383",
                    "r395"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt.  Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper.  Excludes capital lease obligations.",
                            "label":  "Long-term Debt",
                            "totalLabel":  "Long term debt"
                            }
                        }
                    },
                "localname":  "LongTermDebt",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtFairValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure.  Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.  The element may be used in both the balance sheet and disclosure in the same submission.",
                            "label":  "Long-term Debt, Fair Value",
                            "terseLabel":  "Fair value of the Term Loan"
                            }
                        }
                    },
                "localname":  "LongTermDebtFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths":  {
                "auth_ref":  [
                    "r99",
                    "r227"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Long-Term Debt, Maturity, Year One",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour":  {
                "auth_ref":  [
                    "r99",
                    "r227"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Long-Term Debt, Maturity, Year Four",
                            "terseLabel":  "2025"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree":  {
                "auth_ref":  [
                    "r99",
                    "r227"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Long-Term Debt, Maturity, Year Three",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo":  {
                "auth_ref":  [
                    "r99",
                    "r227"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Long-Term Debt, Maturity, Year Two",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear":  {
                "auth_ref":  [
                    "r99"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
                            "label":  "Long-Term Debt, Maturity, Remainder of Fiscal Year",
                            "terseLabel":  "2021 (excluding the three months ended March 31, 2021)"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
                            "label":  "Long-term Debt [Member]",
                            "terseLabel":  "Long term debt"
                            }
                        }
                    },
                "localname":  "LongTermDebtMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LongTermDebtNoncurrent":  {
                "auth_ref":  [
                    "r44"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer.  Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper.  Excludes capital lease obligations.",
                            "label":  "Long-term Debt, Excluding Current Maturities",
                            "terseLabel":  "Long term debt, net"
                            }
                        }
                    },
                "localname":  "LongTermDebtNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongtermDebtTypeAxis":  {
                "auth_ref":  [
                    "r44"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-term debt.",
                            "label":  "Long-term Debt, Type [Axis]",
                            "terseLabel":  "Long-term Debt, Type [Axis]"
                            }
                        }
                    },
                "localname":  "LongtermDebtTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LongtermDebtTypeDomain":  {
                "auth_ref":  [
                    "r44",
                    "r228"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
                            "label":  "Long-term Debt, Type [Domain]",
                            "terseLabel":  "Long-term Debt, Type [Domain]"
                            }
                        }
                    },
                "localname":  "LongtermDebtTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "auth_ref":  [
                    "r75"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
                            "label":  "Net Cash Provided by (Used in) Financing Activities",
                            "totalLabel":  "Net cash flows used in financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Financing Activities [Abstract]",
                            "terseLabel":  "Cash flows from financing activities:"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivities":  {
                "auth_ref":  [
                    "r75"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from investing activities, including discontinued operations.  Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
                            "label":  "Net Cash Provided by (Used in) Investing Activities",
                            "totalLabel":  "Net cash flows used in investing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Investing Activities [Abstract]",
                            "terseLabel":  "Cash\u00a0flows from investing activities:"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "auth_ref":  [
                    "r75",
                    "r78",
                    "r81"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
                            "label":  "Net Cash Provided by (Used in) Operating Activities",
                            "totalLabel":  "Net cash flows used in operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Cash flows from operating activities:"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetIncomeLoss":  {
                "auth_ref":  [
                    "r0",
                    "r58",
                    "r59",
                    "r60",
                    "r81",
                    "r95",
                    "r104",
                    "r109",
                    "r110",
                    "r111",
                    "r112",
                    "r115",
                    "r116",
                    "r123",
                    "r154",
                    "r157",
                    "r160",
                    "r163",
                    "r166",
                    "r182",
                    "r334",
                    "r388",
                    "r402"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  11.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
                            "label":  "Net Income (Loss) Attributable to Parent",
                            "netLabel":  "Net loss",
                            "totalLabel":  "Net loss"
                            }
                        }
                    },
                "localname":  "NetIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic":  {
                "auth_ref":  [
                    "r109",
                    "r110",
                    "r111",
                    "r112",
                    "r117",
                    "r118",
                    "r124",
                    "r127",
                    "r154",
                    "r157",
                    "r160",
                    "r163",
                    "r166"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
                            "label":  "Net Income (Loss) Available to Common Stockholders, Basic",
                            "terseLabel":  "Net loss available to common stockholders",
                            "totalLabel":  "Net loss available to common stockholders",
                            "verboseLabel":  "Net loss available to common stockholders (Note 9)"
                            }
                        }
                    },
                "localname":  "NetIncomeLossAvailableToCommonStockholdersBasic",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
                            "terseLabel":  "Adjustments to reconcile to net (loss) income available to common stockholders"
                            }
                        }
                    },
                "localname":  "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting.  Includes, but is not limited to, quantification of the expected or actual impact.",
                            "label":  "New Accounting Pronouncements, Policy [Policy Text Block]",
                            "terseLabel":  "Recently Issued and Adopted Accounting Standards"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_NoncompeteAgreementsMember":  {
                "auth_ref":  [
                    "r321"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
                            "label":  "Noncompete Agreements [Member]",
                            "terseLabel":  "Non-compete agreements"
                            }
                        }
                    },
                "localname":  "NoncompeteAgreementsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NonoperatingIncomeExpenseAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Nonoperating Income (Expense) [Abstract]",
                            "terseLabel":  "Other expense, net"
                            }
                        }
                    },
                "localname":  "NonoperatingIncomeExpenseAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NotesPayableOtherPayablesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "Notes Payable, Other Payables [Member]",
                            "terseLabel":  "Term loan"
                            }
                        }
                    },
                "localname":  "NotesPayableOtherPayablesMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails",
                    "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NumberOfReportingUnits":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of reporting units tested for impairment of goodwill.  A reporting unit is an operating segment or one level below an operating segment.",
                            "label":  "Number of Reporting Units",
                            "terseLabel":  "Number of reporting units"
                            }
                        }
                    },
                "localname":  "NumberOfReportingUnits",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_OperatingExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Expenses [Abstract]",
                            "terseLabel":  "Operating expenses:"
                            }
                        }
                    },
                "localname":  "OperatingExpensesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingIncomeLoss":  {
                "auth_ref":  [
                    "r154",
                    "r157",
                    "r160",
                    "r163",
                    "r166"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues.",
                            "label":  "Operating Income (Loss)",
                            "totalLabel":  "Operating loss"
                            }
                        }
                    },
                "localname":  "OperatingIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseCost":  {
                "auth_ref":  [
                    "r354",
                    "r361"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term.  Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
                            "label":  "Operating Lease, Cost",
                            "terseLabel":  "Operating lease cost"
                            }
                        }
                    },
                "localname":  "OperatingLeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesLeaseCostsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
                            "terseLabel":  "Operating Leases"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilitiesPaymentsDueAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingLeaseLiability":  {
                "auth_ref":  [
                    "r348"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "mdxg_OperatingLeaseAndFinanceLeaseLiability",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease.",
                            "label":  "Operating Lease, Liability",
                            "terseLabel":  "Right of use liability",
                            "totalLabel":  "Right of use liability"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiability",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesMaturityofLeaseLiabilitiesDetails",
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilityCurrent":  {
                "auth_ref":  [
                    "r348"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
                            "label":  "Operating Lease, Liability, Current",
                            "terseLabel":  "Current right of use liability"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilityNoncurrent":  {
                "auth_ref":  [
                    "r348"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
                            "label":  "Operating Lease, Liability, Noncurrent",
                            "terseLabel":  "Noncurrent right of use liability"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseRightOfUseAsset":  {
                "auth_ref":  [
                    "r347"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's right to use underlying asset under operating lease.",
                            "label":  "Operating Lease, Right-of-Use Asset",
                            "terseLabel":  "Right of use asset"
                            }
                        }
                    },
                "localname":  "OperatingLeaseRightOfUseAsset",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense":  {
                "auth_ref":  [
                    "r80"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense for right-of-use asset from operating lease.",
                            "label":  "Operating Lease, Right-of-Use Asset, Amortization Expense",
                            "terseLabel":  "Amortization of leased assets"
                            }
                        }
                    },
                "localname":  "OperatingLeaseRightOfUseAssetAmortizationExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesLeaseCostsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent":  {
                "auth_ref":  [
                    "r358",
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average discount rate for operating lease calculated at point in time.",
                            "label":  "Operating Lease, Weighted Average Discount Rate, Percent",
                            "terseLabel":  "Weighted-average discount rate"
                            }
                        }
                    },
                "localname":  "OperatingLeaseWeightedAverageDiscountRatePercent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1":  {
                "auth_ref":  [
                    "r357",
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Operating Lease, Weighted Average Remaining Lease Term",
                            "terseLabel":  "Weighted-average remaining lease term (years)"
                            }
                        }
                    },
                "localname":  "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
                            "terseLabel":  "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r1",
                    "r329"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
                            "label":  "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
                            "terseLabel":  "Nature of Business"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NatureofBusiness"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_OtherAccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r8",
                    "r9",
                    "r10",
                    "r41"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/AccruedExpensesDetails":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
                            "label":  "Other Accrued Liabilities, Current",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "OtherAccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/AccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherAssetsCurrent":  {
                "auth_ref":  [
                    "r56"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current assets classified as other.",
                            "label":  "Other Assets, Current",
                            "terseLabel":  "Other current assets"
                            }
                        }
                    },
                "localname":  "OtherAssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherAssetsNoncurrent":  {
                "auth_ref":  [
                    "r37"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncurrent assets classified as other.",
                            "label":  "Other Assets, Noncurrent",
                            "terseLabel":  "Other assets"
                            }
                        }
                    },
                "localname":  "OtherAssetsNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherCurrentAssetsMember":  {
                "auth_ref":  [
                    "r330",
                    "r332"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing other current assets.",
                            "label":  "Other Current Assets [Member]",
                            "terseLabel":  "Other current assets"
                            }
                        }
                    },
                "localname":  "OtherCurrentAssetsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OtherLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r7",
                    "r8",
                    "r41"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
                            "label":  "Other Liabilities, Current",
                            "terseLabel":  "Other current liabilities"
                            }
                        }
                    },
                "localname":  "OtherLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherLiabilitiesNoncurrent":  {
                "auth_ref":  [
                    "r45"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
                            "label":  "Other Liabilities, Noncurrent",
                            "terseLabel":  "Other liabilities"
                            }
                        }
                    },
                "localname":  "OtherLiabilitiesNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r67"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (expense) related to nonoperating activities, classified as other.",
                            "label":  "Other Nonoperating Income (Expense)",
                            "terseLabel":  "Other income, net"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PatentsMember":  {
                "auth_ref":  [
                    "r323"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
                            "label":  "Patents [Member]",
                            "terseLabel":  "Patents and know how"
                            }
                        }
                    },
                "localname":  "PatentsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PayablesAndAccrualsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payables and Accruals [Abstract]",
                            "terseLabel":  "Payables and Accruals [Abstract]"
                            }
                        }
                    },
                "localname":  "PayablesAndAccrualsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PaymentsForLegalSettlements":  {
                "auth_ref":  [
                    "r77"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
                            "label":  "Payments for Legal Settlements",
                            "terseLabel":  "Payments for legal settlements"
                            }
                        }
                    },
                "localname":  "PaymentsForLegalSettlements",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation":  {
                "auth_ref":  [
                    "r73"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
                            "label":  "Payment, Tax Withholding, Share-based Payment Arrangement",
                            "negatedTerseLabel":  "Stock repurchased for tax withholdings on vesting of restricted stock"
                            }
                        }
                    },
                "localname":  "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquireMachineryAndEquipment":  {
                "auth_ref":  [
                    "r71"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for acquisition of machinery and equipment.",
                            "label":  "Payments to Acquire Machinery and Equipment",
                            "negatedTerseLabel":  "Purchases of equipment"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireMachineryAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PerformanceSharesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based payment arrangement awarded for meeting performance target.",
                            "label":  "Performance Shares [Member]",
                            "terseLabel":  "Performance Based Awards"
                            }
                        }
                    },
                "localname":  "PerformanceSharesMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails",
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PreferredClassBMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Outstanding nonredeemable preferred class B stock or outstanding preferred class B stock.  Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer.  Classified within temporary equity if redemption is outside the control of the issuer.",
                            "label":  "Preferred Class B [Member]",
                            "terseLabel":  "Preferred Class B Convertible Stock"
                            }
                        }
                    },
                "localname":  "PreferredClassBMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PreferredStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r21"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
                            "label":  "Preferred Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Preferred stock, par value (in dollars per share)"
                            }
                        }
                    },
                "localname":  "PreferredStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_PreferredStockSharesAuthorized":  {
                "auth_ref":  [
                    "r21"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Preferred Stock, Shares Authorized",
                            "terseLabel":  "Preferred stock, shares authorized (in shares)"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesIssued":  {
                "auth_ref":  [
                    "r21"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury).  May be all or portion of the number of preferred shares authorized.  Excludes preferred shares that are classified as debt.",
                            "label":  "Preferred Stock, Shares Issued",
                            "terseLabel":  "Preferred stock, shares issued (in shares)"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesOutstanding":  {
                "auth_ref":  [
                    "r21"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders.  Does not include preferred shares that have been repurchased.",
                            "label":  "Preferred Stock, Shares Outstanding",
                            "terseLabel":  "Preferred stock, shares outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockValue":  {
                "auth_ref":  [
                    "r21"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Preferred Stock, Value, Issued",
                            "terseLabel":  "Preferred stock Series A; $0.001 par value; 5,000,000 shares authorized, 0 issued and outstanding at March\u00a031, 2021 and December\u00a031, 2020"
                            }
                        }
                    },
                "localname":  "PreferredStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrepaidExpenseAndOtherAssetsCurrent":  {
                "auth_ref":  [
                    "r5",
                    "r32",
                    "r33"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid Expense and Other Assets, Current",
                            "verboseLabel":  "Prepaid expenses"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseAndOtherAssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrimeRateMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Interest rate charged by financial institutions to their most creditworthy borrowers.",
                            "label":  "Prime Rate [Member]",
                            "terseLabel":  "Prime Rate"
                            }
                        }
                    },
                "localname":  "PrimeRateMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ProceedsFromIncomeTaxRefunds":  {
                "auth_ref":  [
                    "r78",
                    "r84"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of cash received during the period as refunds for the overpayment of taxes.",
                            "label":  "Proceeds from Income Tax Refunds",
                            "terseLabel":  "Federal tax refund"
                            }
                        }
                    },
                "localname":  "ProceedsFromIncomeTaxRefunds",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NatureofBusinessDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities":  {
                "auth_ref":  [
                    "r70",
                    "r181"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.",
                            "label":  "Proceeds from Sale and Maturity of Held-to-maturity Securities",
                            "terseLabel":  "Principal payments from note receivable"
                            }
                        }
                    },
                "localname":  "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromStockOptionsExercised":  {
                "auth_ref":  [
                    "r72",
                    "r293"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow from exercise of option under share-based payment arrangement.",
                            "label":  "Proceeds from Stock Options Exercised",
                            "terseLabel":  "Proceeds from exercise of stock options"
                            }
                        }
                    },
                "localname":  "ProceedsFromStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property, Plant and Equipment [Abstract]",
                            "terseLabel":  "Property, Plant and Equipment [Abstract]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentByTypeAxis":  {
                "auth_ref":  [
                    "r36",
                    "r216"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
                            "label":  "Long-Lived Tangible Asset [Axis]",
                            "terseLabel":  "Property, Plant and Equipment, Type [Axis]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock":  {
                "auth_ref":  [
                    "r217",
                    "r419",
                    "r420",
                    "r421"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale.  Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
                            "label":  "Property, Plant and Equipment Disclosure [Text Block]",
                            "terseLabel":  "Property and Equipment"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipment"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentGross":  {
                "auth_ref":  [
                    "r35",
                    "r214"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_PropertyPlantAndEquipmentNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property, Plant and Equipment, Gross",
                            "terseLabel":  "Property and equipment, gross"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentGross",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Property, Plant and Equipment [Line Items]",
                            "terseLabel":  "Property, Plant and Equipment [Line Items]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentNet":  {
                "auth_ref":  [
                    "r14",
                    "r15",
                    "r216",
                    "r398"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        },
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property, Plant and Equipment, Net",
                            "terseLabel":  "Property and equipment, net",
                            "totalLabel":  "Property and equipment, net"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentNet",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTextBlock":  {
                "auth_ref":  [
                    "r14",
                    "r216"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
                            "label":  "Property, Plant and Equipment [Table Text Block]",
                            "terseLabel":  "Summary of Property and Equipment"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTypeDomain":  {
                "auth_ref":  [
                    "r14",
                    "r214"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
                            "label":  "Long-Lived Tangible Asset [Domain]",
                            "terseLabel":  "Property, Plant and Equipment, Type [Domain]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ReceivablesPolicyTextBlock":  {
                "auth_ref":  [
                    "r91",
                    "r175",
                    "r178",
                    "r179",
                    "r180"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for receivable.  Includes, but is not limited to, accounts receivable and financing receivable.",
                            "label":  "Receivable [Policy Text Block]",
                            "terseLabel":  "Accounts Receivable"
                            }
                        }
                    },
                "localname":  "ReceivablesPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RepaymentsOfMediumTermNotes":  {
                "auth_ref":  [
                    "r74"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.",
                            "label":  "Repayments of Medium-term Notes",
                            "negatedTerseLabel":  "Repayment of term loans"
                            }
                        }
                    },
                "localname":  "RepaymentsOfMediumTermNotes",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpense":  {
                "auth_ref":  [
                    "r303",
                    "r422"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
                            "label":  "Research and Development Expense",
                            "terseLabel":  "Research and development"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestrictedStockMember":  {
                "auth_ref":  [
                    "r128"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
                            "label":  "Restricted Stock [Member]",
                            "terseLabel":  "Restricted stock awards"
                            }
                        }
                    },
                "localname":  "RestrictedStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails",
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RestrictedStockUnitsRSUMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
                            "label":  "Restricted Stock Units (RSUs) [Member]",
                            "terseLabel":  "Restricted Stock Unit Awards"
                            }
                        }
                    },
                "localname":  "RestrictedStockUnitsRSUMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails",
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "auth_ref":  [
                    "r25",
                    "r245",
                    "r301",
                    "r396",
                    "r413",
                    "r418"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings (Accumulated Deficit)",
                            "verboseLabel":  "Accumulated deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsMember":  {
                "auth_ref":  [
                    "r101",
                    "r102",
                    "r103",
                    "r105",
                    "r114",
                    "r116",
                    "r186",
                    "r298",
                    "r299",
                    "r300",
                    "r311",
                    "r312",
                    "r409",
                    "r411"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings [Member]",
                            "terseLabel":  "Accumulated Deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax":  {
                "auth_ref":  [
                    "r151",
                    "r152",
                    "r156",
                    "r161",
                    "r162",
                    "r168",
                    "r169",
                    "r171",
                    "r259",
                    "r260",
                    "r374"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_GrossProfit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.  Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
                            "label":  "Revenue from Contract with Customer, Excluding Assessed Tax",
                            "terseLabel":  "Net sales"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerExcludingAssessedTax",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
                    "http://mimedx.com/role/RevenueDatabyCustomerTypeDetails",
                    "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock":  {
                "auth_ref":  [
                    "r92",
                    "r251",
                    "r252",
                    "r253",
                    "r254",
                    "r255",
                    "r256",
                    "r257",
                    "r258",
                    "r266"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for revenue from contract with customer.",
                            "label":  "Revenue from Contract with Customer [Policy Text Block]",
                            "terseLabel":  "Revenue Recognition"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]",
                            "terseLabel":  "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]"
                            }
                        }
                    },
                "localname":  "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable":  {
                "auth_ref":  [
                    "r264"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.",
                            "label":  "Revenue, Initial Application Period Cumulative Effect Transition [Table]",
                            "terseLabel":  "Revenue, Initial Application Period Cumulative Effect Transition [Table]"
                            }
                        }
                    },
                "localname":  "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SalesChannelDirectlyToConsumerMember":  {
                "auth_ref":  [
                    "r263"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract with customer in which good or service is transferred directly to consumer.",
                            "label":  "Sales Channel, Directly to Consumer [Member]",
                            "terseLabel":  "Direct Customers"
                            }
                        }
                    },
                "localname":  "SalesChannelDirectlyToConsumerMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/RevenueDatabyCustomerTypeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SalesChannelThroughIntermediaryMember":  {
                "auth_ref":  [
                    "r263"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract with customer in which good or service is transferred through intermediary.",
                            "label":  "Sales Channel, Through Intermediary [Member]",
                            "terseLabel":  "Distributors"
                            }
                        }
                    },
                "localname":  "SalesChannelThroughIntermediaryMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/RevenueDatabyCustomerTypeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of accrued liabilities.",
                            "label":  "Schedule of Accrued Liabilities [Table Text Block]",
                            "terseLabel":  "Schedule of Accrued Liabilities"
                            }
                        }
                    },
                "localname":  "ScheduleOfAccruedLiabilitiesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/AccruedExpensesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable":  {
                "auth_ref":  [
                    "r128"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
                            "label":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
                            "terseLabel":  "Summary of Antidilutive Securities [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of supplemental cash flow information for the periods presented.",
                            "label":  "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
                            "terseLabel":  "Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities"
                            }
                        }
                    },
                "localname":  "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfDebtTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
                            "label":  "Schedule of Debt [Table Text Block]",
                            "terseLabel":  "Schedule of Debt"
                            }
                        }
                    },
                "localname":  "ScheduleOfDebtTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock":  {
                "auth_ref":  [
                    "r121",
                    "r127",
                    "r132"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the effect of income (loss) on basic earnings per share.",
                            "label":  "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]",
                            "terseLabel":  "Schedule of Earnings Per Share, Basic"
                            }
                        }
                    },
                "localname":  "ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock":  {
                "auth_ref":  [
                    "r121",
                    "r127",
                    "r132"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.",
                            "label":  "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]",
                            "terseLabel":  "Schedule of Earnings Per Share, Diluted"
                            }
                        }
                    },
                "localname":  "ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/NetLossPerCommonShareTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock":  {
                "auth_ref":  [
                    "r168"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
                            "label":  "Revenue from External Customers by Products and Services [Table Text Block]",
                            "terseLabel":  "Summary of Net Sales by Customer Type"
                            }
                        }
                    },
                "localname":  "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/RevenueDatabyCustomerTypeTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable":  {
                "auth_ref":  [
                    "r171"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure about the extent of the entity's reliance on its major customers.",
                            "label":  "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
                            "terseLabel":  "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/RevenueDatabyCustomerTypeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable":  {
                "auth_ref":  [
                    "r200",
                    "r204",
                    "r375"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Schedule of Finite-Lived Intangible Assets [Table]",
                            "terseLabel":  "Schedule of Finite-Lived Intangible Assets [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfFiniteLivedIntangibleAssetsTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails",
                    "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock":  {
                "auth_ref":  [
                    "r200",
                    "r204"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
                            "label":  "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
                            "terseLabel":  "Intangible Assets Activity Summary - Finite-lived"
                            }
                        }
                    },
                "localname":  "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable":  {
                "auth_ref":  [
                    "r208",
                    "r211"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
                            "label":  "Schedule of Indefinite-Lived Intangible Assets [Table]",
                            "terseLabel":  "Schedule of Indefinite-Lived Intangible Assets [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock":  {
                "auth_ref":  [
                    "r208",
                    "r211"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
                            "label":  "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
                            "terseLabel":  "Intangible Assets Activity Summary - Indefinite-lived"
                            }
                        }
                    },
                "localname":  "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfInventoryCurrentTableTextBlock":  {
                "auth_ref":  [
                    "r11",
                    "r29",
                    "r30",
                    "r31"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
                            "label":  "Schedule of Inventory, Current [Table Text Block]",
                            "terseLabel":  "Inventory"
                            }
                        }
                    },
                "localname":  "ScheduleOfInventoryCurrentTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/InventoryTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock":  {
                "auth_ref":  [
                    "r227"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
                            "label":  "Schedule of Maturities of Long-term Debt [Table Text Block]",
                            "terseLabel":  "Future Principal Payments for the Term Loan"
                            }
                        }
                    },
                "localname":  "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock":  {
                "auth_ref":  [
                    "r108",
                    "r111",
                    "r134",
                    "r135"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
                            "label":  "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
                            "terseLabel":  "Assessment of Revenue under ASC 606"
                            }
                        }
                    },
                "localname":  "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable":  {
                "auth_ref":  [
                    "r36",
                    "r216"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
                            "label":  "Property, Plant and Equipment [Table]",
                            "terseLabel":  "Property, Plant and Equipment [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfPropertyPlantAndEquipmentTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable":  {
                "auth_ref":  [
                    "r273",
                    "r292"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about share-based payment arrangement.",
                            "label":  "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
                            "terseLabel":  "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock":  {
                "auth_ref":  [
                    "r275",
                    "r286",
                    "r288"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure for stock option plans.  Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
                            "label":  "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
                            "terseLabel":  "Summary of Stock Options Activity"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
                            "label":  "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
                            "terseLabel":  "Summary of Restricted Stock Awards by Award Type"
                            }
                        }
                    },
                "localname":  "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfStockByClassTable":  {
                "auth_ref":  [
                    "r47",
                    "r93",
                    "r138",
                    "r139",
                    "r233",
                    "r235",
                    "r237",
                    "r239",
                    "r240",
                    "r241",
                    "r242",
                    "r243",
                    "r244",
                    "r245"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule detailing information related to equity by class of stock.  Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer.  It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
                            "label":  "Schedule of Stock by Class [Table]",
                            "terseLabel":  "Schedule of Stock by Class [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockByClassTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock":  {
                "auth_ref":  [
                    "r204"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
                            "label":  "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
                            "terseLabel":  "Estimated Future Amortization Expense for Intangible Assets"
                            }
                        }
                    },
                "localname":  "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SegmentReportingAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Segment Reporting [Abstract]",
                            "terseLabel":  "Segment Reporting [Abstract]"
                            }
                        }
                    },
                "localname":  "SegmentReportingAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SegmentReportingDisclosureTextBlock":  {
                "auth_ref":  [
                    "r148",
                    "r149",
                    "r150",
                    "r154",
                    "r155",
                    "r160",
                    "r164",
                    "r165",
                    "r166",
                    "r167",
                    "r168",
                    "r170",
                    "r171",
                    "r172"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for reporting segments including data and tables.  Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
                            "label":  "Segment Reporting Disclosure [Text Block]",
                            "terseLabel":  "Revenue Data by Customer Type"
                            }
                        }
                    },
                "localname":  "SegmentReportingDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/RevenueDatabyCustomerType"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SellingGeneralAndAdministrativeExpense":  {
                "auth_ref":  [
                    "r65"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses.  Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products.  Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges.  General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
                            "label":  "Selling, General and Administrative Expense",
                            "terseLabel":  "Selling, general and administrative"
                            }
                        }
                    },
                "localname":  "SellingGeneralAndAdministrativeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SeriesBPreferredStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock.  Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer.  Classified within temporary equity if redemption is outside the control of the issuer.",
                            "label":  "Series B Preferred Stock [Member]",
                            "terseLabel":  "Series B Convertible Preferred Stock"
                            }
                        }
                    },
                "localname":  "SeriesBPreferredStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
                    "http://mimedx.com/role/EquityNarrativeDetails",
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensation":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense for share-based payment arrangement.",
                            "label":  "Share-based Payment Arrangement, Noncash Expense",
                            "terseLabel":  "Share-based compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod":  {
                "auth_ref":  [
                    "r280"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
                            "negatedLabel":  "Forfeited (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r285"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Forfeited (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod":  {
                "auth_ref":  [
                    "r283"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
                            "terseLabel":  "Granted (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r283"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Granted (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber":  {
                "auth_ref":  [
                    "r282"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
                            "periodEndLabel":  "Unvested, Ending Balance (in shares)",
                            "periodStartLabel":  "Unvested, Beginning Balance (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
                            "terseLabel":  "Number of Shares"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r282"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement.  Excludes share and unit options.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
                            "periodEndLabel":  "Unvested, Ending Balance (in dollars per share)",
                            "terseLabel":  "Unvested, Beginning Balance (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
                            "terseLabel":  "Weighted-Average Grant Date Fair Value"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod":  {
                "auth_ref":  [
                    "r284"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
                            "negatedLabel":  "Vested (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r284"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Vested (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
                            "terseLabel":  "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
                            "terseLabel":  "Weighted- Average Remaining Contractual Term (in years)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":  {
                "auth_ref":  [
                    "r278"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
                            "terseLabel":  "Exercisable options, vested and expected to vest (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r278"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
                            "terseLabel":  "Exercisable (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod":  {
                "auth_ref":  [
                    "r281"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
                            "negatedTerseLabel":  "Vested options expired (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod":  {
                "auth_ref":  [
                    "r280"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
                            "negatedLabel":  "Unvested options forfeited (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gross number of share options (or share units) granted during the period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
                            "terseLabel":  "Granted (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue":  {
                "auth_ref":  [
                    "r292"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
                            "terseLabel":  "Outstanding"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":  {
                "auth_ref":  [
                    "r277",
                    "r292"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of options outstanding, including both vested and non-vested options.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
                            "periodEndLabel":  "Outstanding, end of period (in shares)",
                            "periodStartLabel":  "Outstanding, beginning of period (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
                            "terseLabel":  "Number of Shares"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r276"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
                            "periodEndLabel":  "Outstanding, end of period (in dollars per share)",
                            "periodStartLabel":  "Outstanding, beginning of period (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
                            "terseLabel":  "Weighted- Average Exercise Price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain":  {
                "auth_ref":  [
                    "r271",
                    "r274"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Award under share-based payment arrangement.",
                            "label":  "Award Type [Domain]",
                            "terseLabel":  "Award Type [Domain]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationRestrictedStockAwardsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
                            "label":  "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Exercised (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
                            "label":  "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Vested options expired (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
                            "label":  "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Unvested options forfeited (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
                            "label":  "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Granted (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1":  {
                "auth_ref":  [
                    "r292"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
                            "terseLabel":  "Exercisable"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1":  {
                "auth_ref":  [
                    "r292"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Exercisable (in years)"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
                            "terseLabel":  "Aggregate Intrinsic Value"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2":  {
                "auth_ref":  [
                    "r289"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Outstanding (in years)"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2":  {
                "auth_ref":  [
                    "r289"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Outstanding Options, weighted average remaining contractual term (in years)"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SharebasedCompensationNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued which are neither cancelled nor held in the treasury.",
                            "label":  "Shares, Outstanding",
                            "periodEndLabel":  "Balance (in shares)",
                            "periodStartLabel":  "Balance (in shares)"
                            }
                        }
                    },
                "localname":  "SharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
                            "label":  "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
                            "terseLabel":  "Shares repurchased for tax withholding (in shares)"
                            }
                        }
                    },
                "localname":  "SharesPaidForTaxWithholdingForShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SignificantAccountingPoliciesTextBlock":  {
                "auth_ref":  [
                    "r100"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for all significant accounting policies of the reporting entity.",
                            "label":  "Significant Accounting Policies [Text Block]",
                            "terseLabel":  "Significant Accounting Policies"
                            }
                        }
                    },
                "localname":  "SignificantAccountingPoliciesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StatementClassOfStockAxis":  {
                "auth_ref":  [
                    "r20",
                    "r21",
                    "r22",
                    "r93",
                    "r95",
                    "r120",
                    "r121",
                    "r122",
                    "r125",
                    "r127",
                    "r138",
                    "r139",
                    "r140",
                    "r182",
                    "r238",
                    "r334"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by the different classes of stock of the entity.",
                            "label":  "Class of Stock [Axis]",
                            "terseLabel":  "Class of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "StatementClassOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "auth_ref":  [
                    "r49",
                    "r101",
                    "r102",
                    "r103",
                    "r105",
                    "r114",
                    "r116",
                    "r137",
                    "r186",
                    "r238",
                    "r245",
                    "r298",
                    "r299",
                    "r300",
                    "r311",
                    "r312",
                    "r336",
                    "r337",
                    "r338",
                    "r339",
                    "r340",
                    "r341",
                    "r409",
                    "r410",
                    "r411"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by component of equity.",
                            "label":  "Equity Components [Axis]",
                            "terseLabel":  "Equity Components [Axis]"
                            }
                        }
                    },
                "localname":  "StatementEquityComponentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Statement [Line Items]",
                            "terseLabel":  "Statement [Line Items]"
                            }
                        }
                    },
                "localname":  "StatementLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Cash Flows [Abstract]",
                            "terseLabel":  "Statement of Cash Flows [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfCashFlowsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Financial Position [Abstract]",
                            "terseLabel":  "Statement of Financial Position [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfFinancialPositionAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Stockholders' Equity [Abstract]",
                            "terseLabel":  "Statement of Stockholders' Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementTable":  {
                "auth_ref":  [
                    "r101",
                    "r102",
                    "r103",
                    "r137",
                    "r374"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
                            "label":  "Statement [Table]",
                            "terseLabel":  "Statement [Table]"
                            }
                        }
                    },
                "localname":  "StatementTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r238",
                    "r245"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares related to Restricted Stock Award forfeited during the period.",
                            "label":  "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited",
                            "terseLabel":  "Restricted stock canceled/forfeited (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r238",
                    "r245"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
                            "label":  "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
                            "negatedTerseLabel":  "Issuance of restricted stock (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r238",
                    "r245",
                    "r279"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of share options (or share units) exercised during the current period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
                            "negatedLabel":  "Exercised (in shares)",
                            "negatedTerseLabel":  "Exercise of stock options (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
                    "http://mimedx.com/role/SharebasedCompensationStockIncentivePlansDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r238",
                    "r245"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of stock related to Restricted Stock Awards forfeited during the period.",
                            "label":  "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures",
                            "negatedTerseLabel":  "Restricted stock canceled/forfeited"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures":  {
                "auth_ref":  [
                    "r238",
                    "r245"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
                            "label":  "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
                            "verboseLabel":  "Issuance of restricted stock"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r245",
                    "r272",
                    "r287"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value, after forfeiture, of shares issued under share-based payment arrangement.  Excludes employee stock ownership plan (ESOP).",
                            "label":  "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
                            "verboseLabel":  "Share-based compensation\u00a0expense"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised":  {
                "auth_ref":  [
                    "r49",
                    "r238",
                    "r245"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of stock issued as a result of the exercise of stock options.",
                            "label":  "Stock Issued During Period, Value, Stock Options Exercised",
                            "terseLabel":  "Exercise of stock options"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquity":  {
                "auth_ref":  [
                    "r22",
                    "r26",
                    "r27",
                    "r95",
                    "r177",
                    "r182",
                    "r334"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.  The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).  This excludes temporary equity and is sometimes called permanent equity.",
                            "label":  "Stockholders' Equity Attributable to Parent",
                            "periodEndLabel":  "Balance, end of period",
                            "periodStartLabel":  "Balance, beginning of period",
                            "totalLabel":  "Total stockholders' deficit"
                            }
                        }
                    },
                "localname":  "StockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders' Equity Attributable to Parent [Abstract]",
                            "terseLabel":  "Stockholders' equity:",
                            "verboseLabel":  "Stockholders' deficit"
                            }
                        }
                    },
                "localname":  "StockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockholdersEquityNoteDisclosureTextBlock":  {
                "auth_ref":  [
                    "r94",
                    "r245",
                    "r248"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income.  Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
                            "label":  "Stockholders' Equity Note Disclosure [Text Block]",
                            "terseLabel":  "Equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/Equity"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StockholdersEquityPolicyTextBlock":  {
                "auth_ref":  [
                    "r90",
                    "r91",
                    "r236"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.",
                            "label":  "Stockholders' Equity, Policy [Policy Text Block]",
                            "terseLabel":  "Treasury Stock"
                            }
                        }
                    },
                "localname":  "StockholdersEquityPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubleaseIncome":  {
                "auth_ref":  [
                    "r355",
                    "r361"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of sublease income excluding finance and operating lease expense.",
                            "label":  "Sublease Income",
                            "terseLabel":  "Sublet income"
                            }
                        }
                    },
                "localname":  "SubleaseIncome",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LeasesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SubsequentEventMember":  {
                "auth_ref":  [
                    "r342",
                    "r364"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
                            "label":  "Subsequent Event [Member]",
                            "terseLabel":  "Subsequent Event"
                            }
                        }
                    },
                "localname":  "SubsequentEventMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SubsequentEventTypeAxis":  {
                "auth_ref":  [
                    "r342",
                    "r364"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
                            "label":  "Subsequent Event Type [Axis]",
                            "terseLabel":  "Subsequent Event Type [Axis]"
                            }
                        }
                    },
                "localname":  "SubsequentEventTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventTypeDomain":  {
                "auth_ref":  [
                    "r342",
                    "r364"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
                            "label":  "Subsequent Event Type [Domain]",
                            "terseLabel":  "Subsequent Event Type [Domain]"
                            }
                        }
                    },
                "localname":  "SubsequentEventTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SubsequentEventsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Events [Abstract]",
                            "terseLabel":  "Subsequent Events [Abstract]"
                            }
                        }
                    },
                "localname":  "SubsequentEventsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventsTextBlock":  {
                "auth_ref":  [
                    "r363",
                    "r366"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.  Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
                            "label":  "Subsequent Events [Text Block]",
                            "terseLabel":  "Subsequent Events"
                            }
                        }
                    },
                "localname":  "SubsequentEventsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SubsequentEvents"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SupplementalCashFlowElementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Supplemental Cash Flow Elements [Abstract]",
                            "terseLabel":  "Supplemental Cash Flow Elements [Abstract]"
                            }
                        }
                    },
                "localname":  "SupplementalCashFlowElementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_TemporaryEquityCarryingAmountAttributableToParent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity.  Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.  Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer.  Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
                            "label":  "Temporary Equity, Carrying Amount, Attributable to Parent",
                            "periodEndLabel":  "Series B Preferred Stock, outstanding, ending",
                            "periodStartLabel":  "Series B Preferred Stock, outstanding, beginning",
                            "terseLabel":  "Convertible preferred stock Series B; $0.001 par value; 100,000 shares authorized, issued and outstanding at March\u00a031, 2021 and December\u00a031, 2020"
                            }
                        }
                    },
                "localname":  "TemporaryEquityCarryingAmountAttributableToParent",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
                    "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_TemporaryEquityParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r12",
                    "r234"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share amount of par value or stated value of stock classified as temporary equity.  Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
                            "label":  "Temporary Equity, Par or Stated Value Per Share",
                            "terseLabel":  "Series B convertible preferred stock par value (in dollars per share)",
                            "verboseLabel":  "Series B convertible preferred stock par value (in dollars per share)"
                            }
                        }
                    },
                "localname":  "TemporaryEquityParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_TemporaryEquitySharesAuthorized":  {
                "auth_ref":  [
                    "r19"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws.  Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.  Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer.  If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity.  If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases.  Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
                            "label":  "Temporary Equity, Shares Authorized",
                            "terseLabel":  "Series B convertible preferred stock, shares authorized (in shares)"
                            }
                        }
                    },
                "localname":  "TemporaryEquitySharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_TemporaryEquitySharesIssued":  {
                "auth_ref":  [
                    "r19"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders.  Securities issued include securities outstanding and securities held in treasury.  Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.  Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer.  If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity.  If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases.  Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
                            "label":  "Temporary Equity, Shares Issued",
                            "terseLabel":  "Series B convertible preferred stock, shares issued (in shares)"
                            }
                        }
                    },
                "localname":  "TemporaryEquitySharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_TemporaryEquitySharesOutstanding":  {
                "auth_ref":  [
                    "r19"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders.  Securities outstanding equals securities issued minus securities held in treasury.  Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.  Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer.  If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity.  If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases.  Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
                            "label":  "Temporary Equity, Shares Outstanding",
                            "periodEndLabel":  "Series B Preferred Stock, outstanding, ending (in shares)",
                            "periodStartLabel":  "Series B Preferred Stock, outstanding, beginning (in shares)",
                            "terseLabel":  "Series B convertible preferred stock, shares outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "TemporaryEquitySharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
                    "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of new stock classified as temporary equity issued during the period.",
                            "label":  "Temporary Equity, Stock Issued During Period, Value, New Issues",
                            "terseLabel":  "Issuance of Series B Preferred Stock"
                            }
                        }
                    },
                "localname":  "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_TemporaryEquityTableTextBlock":  {
                "auth_ref":  [
                    "r12",
                    "r234"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of temporary equity.  Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.  Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer.  If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity.  If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases.  Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
                            "label":  "Temporary Equity [Table Text Block]",
                            "terseLabel":  "Schedule of Series B Preferred Stock"
                            }
                        }
                    },
                "localname":  "TemporaryEquityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/EquityEquityTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_TrademarksAndTradeNamesMember":  {
                "auth_ref":  [
                    "r320"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
                            "label":  "Trademarks and Trade Names [Member]",
                            "terseLabel":  "Trade names and trademarks"
                            }
                        }
                    },
                "localname":  "TrademarksAndTradeNamesMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_TreasuryStockMember":  {
                "auth_ref":  [
                    "r48",
                    "r246"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Shares of an entity that have been repurchased by the entity.  This stock has no voting rights and receives no dividends.  Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital.  Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer.  Classified within temporary equity if redemption is outside the control of the issuer.",
                            "label":  "Treasury Stock [Member]",
                            "terseLabel":  "Treasury Stock"
                            }
                        }
                    },
                "localname":  "TreasuryStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_TreasuryStockShares":  {
                "auth_ref":  [
                    "r48",
                    "r246"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date.  This stock has no voting rights and receives no dividends.",
                            "label":  "Treasury Stock, Shares",
                            "terseLabel":  "Treasury stock, shares (in shares)"
                            }
                        }
                    },
                "localname":  "TreasuryStockShares",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_TreasuryStockValue":  {
                "auth_ref":  [
                    "r48",
                    "r246",
                    "r247"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount allocated to treasury stock.  Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
                            "label":  "Treasury Stock, Value",
                            "negatedTerseLabel":  "Treasury stock at cost; 1,083,297 shares at March\u00a031, 2021 and 1,773,683 shares at December\u00a031, 2020"
                            }
                        }
                    },
                "localname":  "TreasuryStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_TypeOfAdoptionMember":  {
                "auth_ref":  [
                    "r104",
                    "r105",
                    "r106",
                    "r107",
                    "r183",
                    "r184",
                    "r185",
                    "r186",
                    "r187",
                    "r188",
                    "r294",
                    "r295",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r309",
                    "r310",
                    "r311",
                    "r312",
                    "r376",
                    "r377",
                    "r378",
                    "r407",
                    "r408",
                    "r409",
                    "r410",
                    "r411",
                    "r412",
                    "r413",
                    "r414",
                    "r415",
                    "r416",
                    "r417",
                    "r418"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amendment to accounting standards.",
                            "label":  "Accounting Standards Update [Domain]",
                            "terseLabel":  "Type of Adoption [Domain]"
                            }
                        }
                    },
                "localname":  "TypeOfAdoptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_UnusualOrInfrequentItemAxis":  {
                "auth_ref":  [
                    "r69"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
                            "label":  "Unusual or Infrequent Item, or Both [Axis]",
                            "terseLabel":  "Unusual or Infrequent Item, or Both [Axis]"
                            }
                        }
                    },
                "localname":  "UnusualOrInfrequentItemAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IncometaxesDetails",
                    "http://mimedx.com/role/NatureofBusinessDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_UnusualOrInfrequentItemDomain":  {
                "auth_ref":  [
                    "r69"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
                            "label":  "Unusual or Infrequent Item, or Both [Domain]",
                            "terseLabel":  "Unusual or Infrequent Item, or Both [Domain]"
                            }
                        }
                    },
                "localname":  "UnusualOrInfrequentItemDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IncometaxesDetails",
                    "http://mimedx.com/role/NatureofBusinessDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_UnusualOrInfrequentItemLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Unusual or Infrequent Item, or Both [Line Items]",
                            "terseLabel":  "Unusual or Infrequent Item, or Both [Line Items]"
                            }
                        }
                    },
                "localname":  "UnusualOrInfrequentItemLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IncometaxesDetails",
                    "http://mimedx.com/role/NatureofBusinessDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_UnusualOrInfrequentItemTable":  {
                "auth_ref":  [
                    "r69"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about the nature and financial statement effect of an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
                            "label":  "Unusual or Infrequent Item, or Both [Table]",
                            "terseLabel":  "Unusual or Infrequent Item, or Both [Table]"
                            }
                        }
                    },
                "localname":  "UnusualOrInfrequentItemTable",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/IncometaxesDetails",
                    "http://mimedx.com/role/NatureofBusinessDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_UseOfEstimates":  {
                "auth_ref":  [
                    "r141",
                    "r142",
                    "r143",
                    "r144",
                    "r145",
                    "r146",
                    "r147"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
                            "label":  "Use of Estimates, Policy [Policy Text Block]",
                            "terseLabel":  "Use of Estimates"
                            }
                        }
                    },
                "localname":  "UseOfEstimates",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_VariableRateAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of variable rate.",
                            "label":  "Variable Rate [Axis]",
                            "terseLabel":  "Variable Rate [Axis]"
                            }
                        }
                    },
                "localname":  "VariableRateAxis",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_VariableRateDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
                            "label":  "Variable Rate [Domain]",
                            "terseLabel":  "Variable Rate [Domain]"
                            }
                        }
                    },
                "localname":  "VariableRateDomain",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/LongTermDebtTermLoanDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding":  {
                "auth_ref":  [
                    "r119",
                    "r127"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
                            "label":  "Weighted Average Number of Shares Outstanding, Diluted",
                            "terseLabel":  "Weighted average common shares outstanding - diluted (in shares)",
                            "totalLabel":  "Weighted average shares outstanding adjusted for potential common shares"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfDilutedSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic":  {
                "auth_ref":  [
                    "r117",
                    "r127"
                    ],
                "calculation":  {
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
                            "label":  "Weighted Average Number of Shares Outstanding, Basic",
                            "terseLabel":  "Weighted average common shares outstanding - basic (in shares)",
                            "verboseLabel":  "Weighted average shares outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfSharesOutstandingBasic",
                "nsuri":  "http://fasb.org/us-gaap/2020-01-31",
                "presentation":  [
                    "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
                    "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
                    "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
                    ],
                "xbrltype":  "sharesItemType"
                }
            },
        "unitCount":  13
        }
    },
"std_ref":  {
    "r0":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
        },
    "r1":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/topic&trid=2122149"
        },
    "r10":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
        },
    "r100":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/topic&trid=2122369"
        },
    "r101":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
        },
    "r102":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
        },
    "r103":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
        },
    "r104":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
        },
    "r105":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(3)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
        },
    "r106":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(4)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
        },
    "r107":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
        },
    "r108":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
        },
    "r109":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
        },
    "r11":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
        },
    "r110":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
        },
    "r111":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
        },
    "r112":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
        },
    "r113":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
        },
    "r114":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
        },
    "r115":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
        },
    "r116":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
        },
    "r117":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
        },
    "r118":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
        },
    "r119":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
        },
    "r12":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(27)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r120":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
        },
    "r121":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
        },
    "r122":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "55",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
        },
    "r123":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
        },
    "r124":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
        },
    "r125":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
        },
    "r126":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
        },
    "r127":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
        },
    "r128":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
        },
    "r129":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
        },
    "r13":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r130":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
        },
    "r131":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
        },
    "r132":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "52",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
        },
    "r133":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/topic&trid=2144383"
        },
    "r134":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "270",
        "URI":  "http://asc.fasb.org/extlink&oid=116846552&loc=d3e725-108305"
        },
    "r135":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "270",
        "URI":  "http://asc.fasb.org/extlink&oid=116846552&loc=d3e765-108305"
        },
    "r136":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "270",
        "URI":  "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
        },
    "r137":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
        },
    "r138":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
        },
    "r139":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
        },
    "r14":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(13))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r140":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
        },
    "r141":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r142":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r143":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
        },
    "r144":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
        },
    "r145":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
        },
    "r146":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
        },
    "r147":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
        },
    "r148":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
        },
    "r149":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
        },
    "r15":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(14))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r150":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
        },
    "r151":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r152":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r153":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r154":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
        },
    "r155":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "26",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
        },
    "r156":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
        },
    "r157":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
        },
    "r158":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
        },
    "r159":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
        },
    "r16":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(19))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r160":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
        },
    "r161":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
        },
    "r162":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
        },
    "r163":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
        },
    "r164":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
        },
    "r165":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
        },
    "r166":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
        },
    "r167":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "34",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
        },
    "r168":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
        },
    "r169":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
        },
    "r17":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(20))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r170":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
        },
    "r171":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "42",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
        },
    "r172":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/topic&trid=2134510"
        },
    "r173":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
        },
    "r174":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
        },
    "r175":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
        },
    "r176":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
        },
    "r177":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
        },
    "r178":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
        },
    "r179":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
        },
    "r18":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(22))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r180":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
        },
    "r181":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "320",
        "URI":  "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
        },
    "r182":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "323",
        "URI":  "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r183":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
        },
    "r184":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
        },
    "r185":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
        },
    "r186":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
        },
    "r187":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(3)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
        },
    "r188":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(4)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
        },
    "r189":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "330",
        "URI":  "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
        },
    "r19":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27)(b))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r190":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "330",
        "URI":  "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
        },
    "r191":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "330",
        "URI":  "http://asc.fasb.org/topic&trid=2126998"
        },
    "r192":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
        },
    "r193":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
        },
    "r194":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
        },
    "r195":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(e)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
        },
    "r196":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
        },
    "r197":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
        },
    "r198":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
        },
    "r199":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
        },
    "r2":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
        },
    "r20":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r200":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r201":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r202":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r203":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "((a)(1),(b))",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r204":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r205":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(1)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r206":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(2)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r207":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(3)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r208":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r209":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r21":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r210":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)(1)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r211":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b),(d)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
        },
    "r212":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/topic&trid=2144416"
        },
    "r213":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r214":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r215":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r216":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r217":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/topic&trid=2155823"
        },
    "r218":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "410",
        "URI":  "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
        },
    "r219":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(3)",
        "Topic":  "410",
        "URI":  "http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
        },
    "r22":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r220":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
        },
    "r221":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
        },
    "r222":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/topic&trid=2144648"
        },
    "r223":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
        },
    "r224":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
        },
    "r225":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751"
        },
    "r226":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/topic&trid=2127136"
        },
    "r227":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
        },
    "r228":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
        },
    "r229":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
        },
    "r23":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(3))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r230":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
        },
    "r231":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
        },
    "r232":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/topic&trid=2208564"
        },
    "r233":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(CFRR 211.02)",
        "Topic":  "480",
        "URI":  "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
        },
    "r234":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Topic":  "480",
        "URI":  "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
        },
    "r235":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
        },
    "r236":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21459-112644"
        },
    "r237":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
        },
    "r238":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
        },
    "r239":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
        },
    "r24":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r240":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
        },
    "r241":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
        },
    "r242":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
        },
    "r243":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
        },
    "r244":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
        },
    "r245":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3-04)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
        },
    "r246":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
        },
    "r247":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
        },
    "r248":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/topic&trid=2208762"
        },
    "r249":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
        },
    "r25":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r250":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
        },
    "r251":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
        },
    "r252":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
        },
    "r253":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
        },
    "r254":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
        },
    "r255":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
        },
    "r256":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
        },
    "r257":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
        },
    "r258":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
        },
    "r259":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
        },
    "r26":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r260":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
        },
    "r261":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
        },
    "r262":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "27",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130611-203046-203046"
        },
    "r263":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
        },
    "r264":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(i)(1)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
        },
    "r265":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
        },
    "r266":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/topic&trid=49130388"
        },
    "r267":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(i)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r268":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(d)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
        },
    "r269":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(f)(3)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
        },
    "r27":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r270":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "80",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
        },
    "r271":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
        },
    "r272":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
        },
    "r273":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
        },
    "r274":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a),(g)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r275":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r276":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r277":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)-(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r278":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r279":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r28":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r280":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(3)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r281":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(4)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r282":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(i)-(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r283":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r284":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r285":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(3)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r286":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r287":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r288":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r289":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r29":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(6)(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r290":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r291":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r292":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r293":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
        },
    "r294":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r295":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r296":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r297":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r298":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r299":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r3":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
        },
    "r30":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(6)(b))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r300":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r301":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(g)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r302":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/topic&trid=2228938"
        },
    "r303":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "730",
        "URI":  "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
        },
    "r304":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
        },
    "r305":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
        },
    "r306":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
        },
    "r307":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
        },
    "r308":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
        },
    "r309":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740"
        },
    "r31":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(6)(c))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r310":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740"
        },
    "r311":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "740"
        },
    "r312":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(3)",
        "Topic":  "740"
        },
    "r313":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.5.Q1)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
        },
    "r314":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.7)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
        },
    "r315":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.C)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
        },
    "r316":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
        },
    "r317":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "270",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
        },
    "r318":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
        },
    "r319":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/topic&trid=2144680"
        },
    "r32":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(7))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r320":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
        },
    "r321":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Subparagraph":  "(e)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
        },
    "r322":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
        },
    "r323":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "38",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
        },
    "r324":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r325":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r326":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
        },
    "r327":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bb)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
        },
    "r328":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
        },
    "r329":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/topic&trid=2197479"
        },
    "r33":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(8))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r330":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
        },
    "r331":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
        },
    "r332":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "182",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
        },
    "r333":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6A",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "20",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=121607252&loc=SL5864739-113975"
        },
    "r334":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "825",
        "URI":  "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
        },
    "r335":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "230",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
        },
    "r336":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
        },
    "r337":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r338":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r339":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r34":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.1)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r340":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r341":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
        },
    "r342":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
        },
    "r343":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
        },
    "r344":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
        },
    "r345":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
        },
    "r346":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
        },
    "r347":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
        },
    "r348":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
        },
    "r349":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
        },
    "r35":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.13)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r350":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
        },
    "r351":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
        },
    "r352":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)(3)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
        },
    "r353":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
        },
    "r354":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
        },
    "r355":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(e)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
        },
    "r356":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(1)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
        },
    "r357":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(3)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
        },
    "r358":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(4)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
        },
    "r359":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
        },
    "r36":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.14)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r360":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
        },
    "r361":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "53",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
        },
    "r362":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/subtopic&trid=77888251"
        },
    "r363":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "855",
        "URI":  "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
        },
    "r364":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "855",
        "URI":  "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
        },
    "r365":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "855",
        "URI":  "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
        },
    "r366":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "855",
        "URI":  "http://asc.fasb.org/topic&trid=2122774"
        },
    "r367":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r368":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r369":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r37":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.17)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r370":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r371":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r372":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r373":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "910",
        "URI":  "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
        },
    "r374":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.L)",
        "Topic":  "924",
        "URI":  "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
        },
    "r375":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "926",
        "URI":  "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
        },
    "r376":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "926",
        "URI":  "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
        },
    "r377":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "926",
        "URI":  "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
        },
    "r378":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "926",
        "URI":  "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
        },
    "r379":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "340",
        "Topic":  "928",
        "URI":  "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
        },
    "r38":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r380":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(10)(1))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r381":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r382":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(13))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r383":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(16))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r384":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r385":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.10)",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r386":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.15(5))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r387":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.17)",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r388":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r389":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(27))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r39":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a),20,24)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r390":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04.10)",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r391":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "470",
        "Subparagraph":  "(c)",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
        },
    "r392":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "470",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
        },
    "r393":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(16))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r394":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r395":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(16))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r396":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r397":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r398":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(8))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r399":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.(a),19)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r4":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
        },
    "r40":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19-26)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r400":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.15(a))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r401":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.5(c))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r402":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r403":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(23))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r404":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(9))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r405":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(d)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
        },
    "r406":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29F",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
        },
    "r407":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r408":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(b)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r409":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r41":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r410":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(1)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r411":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(2)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r412":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(1)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r413":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(i)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r414":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(ii)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r415":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(iii)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r416":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(iv)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r417":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(1)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r418":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(2)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
        },
    "r419":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Subparagraph":  "(d)",
        "Topic":  "958",
        "URI":  "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
        },
    "r42":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r420":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "958",
        "URI":  "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
        },
    "r421":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "958",
        "URI":  "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
        },
    "r422":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "985",
        "URI":  "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
        },
    "r423":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b"
        },
    "r424":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "d1-1"
        },
    "r425":  {
        "Name":  "Form 10-Q",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "308",
        "Subsection":  "a"
        },
    "r426":  {
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13",
        "Subsection":  "a-1"
        },
    "r427":  {
        "Name":  "Regulation 12B",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-2"
        },
    "r428":  {
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r43":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22(a)(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r44":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r45":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.24)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r46":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.25)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r47":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.28,29)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r48":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29,30)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r49":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r5":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
        },
    "r50":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.3(a)(4))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r51":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.6(a)(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r52":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.6(a)(3))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r53":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.6(a)(4))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r54":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.6(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r55":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.6(b))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r56":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.8)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r57":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.9)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r58":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
        },
    "r59":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
        },
    "r6":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
        },
    "r60":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r61":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(25))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r62":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(8))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r63":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.1,2)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r64":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.2(a),(d))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r65":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r66":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.8)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r67":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.9)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r68":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "8",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
        },
    "r69":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
        },
    "r7":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
        },
    "r70":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
        },
    "r71":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
        },
    "r72":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
        },
    "r73":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
        },
    "r74":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
        },
    "r75":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
        },
    "r76":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
        },
    "r77":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
        },
    "r78":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
        },
    "r79":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
        },
    "r8":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
        },
    "r80":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
        },
    "r81":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
        },
    "r82":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
        },
    "r83":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
        },
    "r84":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
        },
    "r85":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
        },
    "r86":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
        },
    "r87":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
        },
    "r88":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
        },
    "r89":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/topic&trid=2134446"
        },
    "r9":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
        },
    "r90":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
        },
    "r91":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
        },
    "r92":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
        },
    "r93":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(d))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r94":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(e)(1))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r95":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r96":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r97":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(e),(f))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r98":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(h)(1)(i))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r99":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.12-04.(a))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
        }
    },
"version":  "2.1"
}


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/27/21  Mimedx Group, Inc.                S-3                    8:2.2M                                   Donnelley … Solutions/FA


3 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/21/21  Mimedx Group, Inc.                8-K:5,9     4/19/21   12:465K                                   Donnelley … Solutions/FA
 3/30/21  Mimedx Group, Inc.                8-K:4,9     3/25/21   13:178K
 3/08/21  Mimedx Group, Inc.                10-K       12/31/20  111:12M
Top
Filing Submission 0001376339-21-000032   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 6:54:42.3pm ET